rfhg_136277.1

Basic information about the TSS

---

TSS ID: rfhg_136277.1 Species: human Chr: chr11		Start: 44934464 End: 44934555 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF010315:-24 GeneID: 9537 HGNC/MGI_ID: HGNC:16842 UniProt_ID: Nearer transcript ids and distances:

Gene_name: TP53I11 Gene_symbol: TP53I11 Gene_synonyms: PIG11 Gene_source: HGNC:16842

TATA-Box annotation

---

Distance to TSS:	15651
Nearest PromoterID:	NM_001258320
Entrez ID:	9537
Nearest Unigene:	Hs.554791
Nearest Refseq:	NM_006034
Nearest Ensembl:	ENSG00000175274
Gene Name:	TP53I11
Gene Alias:	PIG11
Gene Type:	protein-coding
CpG%:	0.010989
GC%:	0.586957
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TP53I11 p2@TP53I11 p3@TP53I11 p4@TP53I11 p5@TP53I11 p6@TP53I11 p7@TP53I11 p8@TP53I11 p9@TP53I11 p10@TP53I11
Sample		p1@TP53I11	p2@TP53I11	p3@TP53I11	p4@TP53I11	p5@TP53I11	p6@TP53I11	p7@TP53I11	p8@TP53I11	p9@TP53I11	p10@TP53I11
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.55	0.39	2.53	0.39	0.00	0.00	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.31	0.20	2.23	1.01	0.20	0.20	0.00	0.00	0.40	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.91	0.77	2.51	0.96	0.00	0.00	0.19	0.00	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.24	0.62	1.25	0.42	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.45	0.22	1.57	0.67	0.00	0.00	0.00	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.20	0.39	2.13	0.58	0.39	0.58	0.00	0.00	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.24	0.87	3.27	1.31	0.00	0.00	0.00	0.00	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	10.90	0.73	2.66	1.45	0.00	0.00	0.00	0.00	0.48	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.47	0.64	2.35	1.28	0.00	0.43	0.21	0.00	1.07	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	9.27	0.00	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.26	0.00	2.02	0.40	0.00	0.00	0.00	0.40	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.16	0.41	1.22	1.22	0.00	0.00	0.00	0.00	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	8.22	1.77	3.87	1.45	0.64	0.16	0.00	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.31	1.95	1.80	1.35	0.90	0.15	0.30	0.30	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.59	2.42	2.20	1.76	0.88	0.44	0.00	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.05	1.76	4.28	1.26	1.01	0.50	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.64	2.18	3.49	1.31	0.22	0.22	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.01	3.37	3.80	3.37	1.27	0.00	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.40	0.00	2.13	1.07	1.07	0.00	0.53	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	6.02	1.65	1.96	0.60	0.60	0.15	0.30	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.42	2.81	3.07	1.74	0.00	0.00	0.27	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	4.14	1.90	3.80	2.59	0.35	0.35	0.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	5.56	2.20	2.33	1.55	0.39	0.26	0.26	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.82	2.67	3.64	2.18	0.73	0.00	0.49	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.51	1.55	6.45	2.32	0.00	0.00	0.52	0.00	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	5.06	2.22	4.11	2.22	0.95	0.00	0.32	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	4.40	2.20	5.49	1.65	0.55	0.00	0.55	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.43	2.59	4.24	2.36	0.71	0.24	0.71	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	6.30	2.10	3.23	1.45	0.65	0.48	0.48	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	6.88	2.17	4.52	1.09	0.36	0.18	0.72	0.36	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.70	1.88	3.14	0.84	0.21	0.21	0.00	0.00	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.42	2.15	5.08	2.34	0.20	0.20	0.20	0.59	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.17	2.32	5.91	1.90	0.21	0.42	0.21	0.00	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	3.96	1.32	4.29	1.98	0.49	0.66	0.16	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.36	2.24	2.99	1.50	0.37	0.56	0.37	0.56	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.13	1.72	4.41	1.34	0.96	0.00	0.38	0.00	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	5.31	2.04	4.09	1.84	0.20	0.41	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	4.84	1.41	1.81	0.60	0.20	0.40	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.56	0.81	2.97	2.97	1.35	0.54	0.27	0.00	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	2.64	1.20	3.36	1.20	0.72	0.00	0.24	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.76	0.24	4.23	1.18	0.47	0.24	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	3.07	0.88	2.78	1.61	0.59	0.15	0.44	0.44	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	3.80	1.48	1.27	1.05	1.48	0.63	0.21	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.92	1.22	4.72	1.75	0.52	0.00	0.00	0.00	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.03	2.21	3.01	1.41	0.40	0.00	0.00	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.05	2.79	3.95	1.40	0.23	0.23	0.00	0.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.96	1.44	4.08	1.44	0.72	0.00	0.00	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	3.87	2.38	3.58	0.30	0.60	0.30	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.94	1.91	1.91	1.20	0.24	0.00	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.67	0.81	2.43	1.01	0.40	0.00	0.40	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	4.71	1.23	4.10	2.87	0.20	0.00	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.89	2.67	4.89	2.67	0.22	0.00	0.22	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	41.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	3.19	1.06	1.77	0.71	0.00	0.00	1.42	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.30	3.65	2.65	0.66	0.99	0.00	0.33	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1.68	0.00	27.68	14.26	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	3.21	0.46	9.64	4.59	0.00	0.00	0.00	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	3.89	0.32	3.89	0.32	0.00	0.00	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.82	0.96	4.18	1.93	0.00	0.64	0.96	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1.57	0.00	13.20	3.14	0.00	0.31	0.00	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3.53	2.82	3.53	1.41	0.71	0.71	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.36	1.68	3.93	0.00	0.00	0.00	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2.39	0.00	44.58	16.72	0.00	0.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	2.72	0.68	11.21	3.74	0.34	0.34	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.45	1.95	8.45	2.27	0.00	0.65	0.00	0.00	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.68	0.35	6.74	2.13	1.06	0.00	0.00	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	96.98	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	47.38	23.69	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	0.98	6.83	2.93	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.94	1.49	2.98	0.99	0.50	1.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.10	1.88	3.75	0.47	0.00	0.00	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.97	1.66	7.29	2.65	0.00	0.33	0.00	0.00	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.73	0.93	2.78	1.55	0.93	0.31	0.00	0.93	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.95	1.22	3.97	0.92	0.00	0.31	0.00	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	50.84	53.53	16.31	12.83	1.90	3.96	3.01	2.22	2.38	2.06
Adipocyte - breast, donor2	11327-117E4	26.63	40.59	21.82	26.47	1.12	3.05	0.96	1.76	0.32	0.64
Adipocyte - omental, donor1	11473-119C6	58.65	57.89	19.72	27.48	3.18	3.69	2.16	1.65	1.40	2.42
Adipocyte - omental, donor2	11474-119C7	19.43	35.88	7.47	11.96	2.24	4.48	0.00	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	21.77	29.47	11.39	10.38	1.34	1.34	0.33	0.67	0.33	1.67
Adipocyte - perirenal, donor1	11476-119C9	27.43	40.19	17.86	23.61	3.19	7.66	4.47	0.64	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	24.19	5.50	4.40	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	12.19	8.58	2.26	2.71	0.00	0.00	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.76	16.51	2.61	3.13	1.22	1.22	0.35	0.87	0.35	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	27.97	12.13	1.37	3.13	0.39	0.98	0.20	0.20	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	16.47	6.18	1.54	2.06	0.00	0.26	0.26	0.00	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	18.96	6.13	2.51	0.84	0.84	0.00	0.56	0.84	1.95	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	14.70	1.76	0.59	1.18	1.18	0.00	0.00	0.00	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	19.63	7.96	1.05	2.82	0.88	0.32	0.32	0.32	0.40	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	15.49	7.10	3.87	0.97	0.97	0.00	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	17.06	5.33	1.60	3.73	0.53	0.53	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.69	2.23	0.56	1.11	0.56	0.56	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	3.33	1.25	0.83	0.42	0.42	0.00	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	9.80	4.77	1.00	1.26	0.50	0.50	0.50	0.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	12.76	4.25	2.29	1.64	0.98	0.00	0.33	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	6.09	2.13	0.91	0.00	0.30	0.30	0.30	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	25.19	13.04	2.87	2.87	1.33	0.44	2.21	0.66	1.99	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	21.51	5.74	0.36	3.23	2.51	0.72	2.87	1.43	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	5.99	0.00	5.99	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	0.21	0.21	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	1.03	0.69	0.23	0.11	0.11	0.11	0.23	0.11	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	1.96	0.49	0.00	0.24	1.22	0.00	0.24	0.00	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	3.15	0.45	0.90	0.45	0.90	0.00	0.00	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	0.00	0.43	0.87	0.00	0.00	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	2.39	1.20	1.20	0.90	0.00	0.00	0.00	0.00	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1.26	1.26	2.53	1.26	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	2.64	0.66	1.32	0.00	1.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	2.27	0.32	0.97	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	2.43	0.97	0.97	0.00	0.00	0.00	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	0.59	1.19	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.90	0.00	0.38	1.51	0.00	0.38	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	3.63	0.73	0.73	0.00	0.00	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	0.00	0.00	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	2.80	1.48	0.33	0.16	0.16	0.00	0.16	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	2.56	0.75	0.30	0.45	0.00	0.00	0.15	0.00	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.75	0.00	1.61	1.07	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.72	0.94	0.57	0.57	0.19	0.19	0.00	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	3.47	1.60	1.07	0.53	0.00	0.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	4.88	0.98	1.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	3.65	1.66	0.17	0.66	0.17	0.17	0.17	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	3.95	2.40	1.03	1.20	0.17	0.00	0.17	0.00	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	3.40	0.49	0.97	0.97	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	2.66	0.76	0.38	0.38	0.00	0.38	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	2.28	0.57	0.57	0.57	0.00	0.00	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	3.85	1.50	0.43	0.21	0.21	0.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.10	1.81	0.77	0.52	0.00	0.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	0.94	0.47	0.94	0.00	0.00	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	1.61	1.29	0.96	0.00	0.00	0.00	0.00	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	0.71	0.00	0.71	0.00	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1.75	1.17	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	2.41	0.60	1.20	0.00	0.30	0.30	0.00	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	1.19	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	1.02	1.53	0.51	0.00	0.51	0.00	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	1.78	2.04	0.76	1.02	0.00	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.18	0.64	0.00	0.64	0.00	1.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	4.32	0.00	2.59	1.29	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	2.75	0.64	0.21	0.64	0.00	0.00	0.21	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.06	1.74	0.58	0.29	0.29	0.29	0.00	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	0.94	0.00	0.94	0.94	0.00	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	2.71	1.53	0.85	0.68	0.00	0.00	0.00	0.17	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	0.00	2.11	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.72	0.86	1.29	1.07	0.21	0.21	0.00	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	2.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1.46	0.00	2.19	0.00	0.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	3.45	1.15	0.23	1.15	0.00	0.69	0.46	0.00	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	7.65	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1.78	0.76	0.51	0.25	0.25	0.00	0.00	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	2.68	1.24	0.41	0.62	0.00	0.00	0.00	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.37	1.22	1.53	0.61	0.00	0.00	0.00	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	2.39	0.96	0.96	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.77	1.33	1.11	0.89	0.22	0.44	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.22	2.22	0.55	0.00	0.00	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.71	1.32	0.53	0.79	0.26	0.26	0.00	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1.09	0.36	1.45	0.36	0.00	0.36	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	14.37	4.91	0.61	1.72	0.25	0.49	0.00	0.25	0.00	0.49
Astrocyte - cerebellum, donor2	11580-120F5	13.18	4.28	2.05	1.20	0.17	1.03	0.17	0.17	0.34	0.17
Astrocyte - cerebellum, donor3	11661-122F5	15.52	6.08	2.73	2.10	0.84	0.21	0.00	0.00	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	10.81	3.83	0.35	1.74	0.35	0.00	0.00	0.00	0.35	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	11.00	2.91	0.97	0.81	0.32	0.16	0.16	0.16	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	15.36	2.83	1.49	2.09	0.15	0.15	0.15	0.30	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.11	0.00	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	2.88	1.31	0.00	0.26	0.52	0.00	0.00	0.52	0.26	0.26
Basophils, donor2	12242-129H1	5.05	0.36	0.00	0.36	0.00	0.00	0.00	0.00	0.36	0.00
Basophils, donor3	12243-129H2	5.59	2.20	0.29	0.44	0.44	0.00	0.15	0.15	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	1.72	1.08	0.22	0.43	0.22	0.00	0.22	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.00	0.00	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	1.88	0.63	1.26	0.00	0.00	0.00	0.00	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.25	0.21	0.00	0.21	0.00	0.00	0.21	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	0.00	0.69	0.00	0.92	0.00	0.00	0.23	0.46	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	0.72	0.18	1.08	0.00	0.00	0.36	0.18	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.62	0.00	0.10	0.10	0.00	0.10	0.00	0.00	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	4.48	0.64	0.32	0.64	0.00	0.00	0.00	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	7.89	1.13	1.13	0.56	1.69	0.00	0.00	1.13	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	7.24	2.60	2.78	2.78	0.74	0.74	0.19	0.00	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	4.83	1.98	1.76	1.98	0.66	0.22	0.44	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1.13	0.00	0.00	0.28	0.28	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	3.41	0.76	0.00	0.00	0.38	0.00	0.00	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	2.96	0.33	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	5.64	3.18	2.89	3.76	0.72	0.29	0.14	0.29	0.14	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	3.02	3.32	2.11	0.30	0.30	0.00	0.00	0.30	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	5.69	4.03	0.95	1.42	1.18	0.00	0.71	0.71	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	2.51	0.67	0.84	1.84	0.33	0.33	0.50	0.17	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.76	1.38	1.66	0.28	0.00	0.00	0.00	0.55	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.23	1.74	0.25	1.24	1.74	0.25	0.00	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.13	1.17	1.17	1.17	0.20	0.59	0.20	0.00	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.31	1.60	1.25	0.71	0.71	0.00	0.00	0.71	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.31	0.87	0.87	0.87	0.44	0.00	0.22	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.28	0.94	0.70	0.70	0.47	0.00	0.00	0.47	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.06	3.17	0.00	0.53	2.11	0.00	0.00	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.16	1.49	2.08	1.34	0.74	0.89	0.15	0.15	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.20	1.00	1.40	0.80	1.00	0.20	0.00	0.80	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.12	0.21	0.42	0.62	1.04	0.00	0.21	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3.20	1.37	0.92	1.60	0.23	0.00	0.46	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.71	0.90	0.45	0.45	0.23	0.00	0.00	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.75	0.00	0.87	0.87	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.96	1.34	0.81	1.34	0.54	0.00	0.00	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.01	1.74	2.09	1.57	1.05	0.00	0.00	0.35	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4.21	0.84	0.42	0.42	0.84	0.42	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	0.37	2.20	1.65	0.73	0.00	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.41	1.41	0.00	0.35	0.00	0.00	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.75	1.32	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.14	1.22	1.22	1.74	0.35	0.00	0.00	0.17	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1.86	1.49	2.23	1.49	0.00	0.37	0.00	0.00	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2.80	0.86	0.43	1.08	0.65	0.22	0.43	0.43	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	2.05	1.64	3.69	2.87	0.41	0.00	0.82	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.85	0.46	0.70	0.23	0.23	0.00	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.16	0.23	0.46	0.00	0.23	0.00	0.00	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	1.53	0.87	0.22	0.00	0.00	0.22	0.22	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	2.08	1.39	0.46	0.69	0.00	0.46	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	2.82	0.65	0.00	0.22	0.00	0.00	0.43	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	6.07	2.49	0.78	0.93	0.93	0.00	0.47	0.16	0.31	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	6.64	1.05	0.17	0.70	0.00	0.17	0.35	0.00	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	7.80	1.11	2.23	1.11	0.67	0.22	0.22	0.45	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	5.87	3.06	0.26	0.26	0.51	0.00	0.00	0.00	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	4.83	2.63	0.00	1.10	0.00	0.00	0.66	0.44	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	4.63	2.53	0.63	0.21	0.21	0.00	0.63	0.42	0.00	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	2.03	0.00	0.00	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	13.56	3.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	16.57	2.07	0.00	0.00	0.00	0.00	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	19.72	3.20	0.53	0.00	0.00	0.53	0.00	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	24.66	3.22	0.00	0.00	0.00	0.54	0.00	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.95	3.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	15.69	3.92	1.57	0.78	0.00	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	28.77	3.29	1.64	3.29	0.00	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	29.02	3.63	3.63	5.08	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	16.66	4.54	3.03	2.52	0.00	0.00	0.00	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	3.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	1.69	1.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	2.63	1.13	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2.93	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	1.43	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	1.84	0.61	1.84	0.61	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	2.13	0.00	0.61	0.61	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.43	0.00	0.00	0.29	0.00	0.00	0.00	0.00	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1.36	0.34	0.51	0.17	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.97	0.16	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	2.80	0.35	0.00	0.35	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	3.08	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.42	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	3.95	1.04	1.66	0.00	0.00	0.42	0.00	0.00	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	3.34	0.33	0.67	0.33	0.33	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.37	0.00	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	3.03	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1.31	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	8.41	0.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	6.46	1.85	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	4.19	0.00	0.00	1.40	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	6.65	1.66	0.00	0.55	0.00	0.00	0.00	0.00	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	12.02	1.23	0.49	0.98	0.00	0.49	0.00	0.00	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	12.32	1.54	1.54	0.00	0.00	0.00	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	10.74	1.43	0.72	0.72	0.00	0.36	0.00	0.36	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	13.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	27.83	5.24	2.29	1.96	0.00	0.65	0.33	0.00	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	21.40	4.88	4.88	3.38	0.38	0.38	0.38	0.00	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	11.36	1.51	2.27	0.76	0.00	0.00	0.00	0.00	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	12.62	1.38	4.59	2.06	0.23	0.23	0.23	0.00	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.98	3.12	10.78	4.55	0.72	0.24	0.00	0.00	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.04	3.83	10.12	4.92	0.27	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.60	3.90	5.10	2.70	0.30	0.60	0.00	0.00	1.20	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.68	2.64	4.56	2.64	0.24	0.24	0.00	0.48	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14.78	3.64	1.82	0.68	0.00	0.00	0.00	0.00	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.78	4.35	5.00	3.04	0.22	0.43	0.22	0.00	0.22	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	14.74	3.42	4.21	1.84	0.26	0.00	0.00	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	17.82	3.52	4.22	1.17	0.47	0.00	0.00	0.00	0.94	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	19.62	2.72	7.25	2.72	0.00	0.60	0.00	0.00	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.69	2.32	4.36	2.03	0.29	0.00	0.00	0.29	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.72	4.26	1.07	1.60	0.53	0.27	0.00	0.00	0.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.76	3.06	0.88	0.44	0.44	0.44	0.00	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	12.75	5.92	1.82	0.00	0.00	0.00	0.00	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	5.22	0.75	2.98	1.49	0.00	0.00	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.89	4.68	1.80	2.16	0.36	0.00	0.00	0.36	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.39	4.60	2.30	2.88	0.00	0.29	0.00	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.96	3.77	1.65	3.77	0.24	0.47	0.24	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.92	2.85	4.12	1.58	0.32	0.63	0.00	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.68	4.00	3.08	1.85	0.31	0.00	0.00	0.00	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.35	4.81	1.60	1.28	0.00	0.32	0.00	0.00	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.21	4.59	2.68	1.15	0.00	0.38	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.43	5.52	4.73	1.58	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	0.76	2.27	2.27	0.00	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.06	3.21	7.23	0.00	0.80	0.80	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.29	8.39	4.20	2.80	2.10	0.00	0.00	0.70	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	17.03	8.01	1.00	2.00	0.00	0.00	1.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	14.62	16.45	80.42	62.14	0.00	0.00	0.00	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	20.26	8.40	4.45	3.95	1.98	0.49	0.49	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	78.50	59.04	6.00	4.84	2.53	1.37	0.74	1.05	2.10	1.16
Chondrocyte - de diff, donor1	11261-116G1	5.89	1.04	4.51	3.47	0.35	0.00	0.69	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	9.24	7.46	1.07	2.13	0.71	0.36	0.00	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	4.89	5.46	3.41	2.05	0.68	0.23	0.23	0.23	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	6.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	2.43	2.02	0.00	1.21	0.00	0.00	0.00	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	4.71	0.69	0.34	0.46	0.11	0.23	0.00	0.00	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	4.92	0.64	1.07	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	5.75	1.33	0.62	0.53	0.09	0.00	0.18	0.00	0.09	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.70	3.94	2.38	2.57	0.46	0.46	0.55	0.37	0.46	4.13
Corneal Epithelial Cells, donor1	11526-119I5	3.51	0.44	0.00	0.22	0.22	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	0.00	0.00	0.00	0.00	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.60	0.77	0.26	0.51	0.26	0.00	0.00	0.51	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	22.12	8.42	2.64	1.16	0.50	0.00	0.66	0.00	0.33	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.81	8.52	1.58	0.95	0.63	0.00	0.32	0.00	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	0.00	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	22.14	11.55	4.32	2.16	0.65	1.19	0.32	0.32	0.22	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	82.68	27.33	2.73	3.42	0.34	0.68	0.00	0.00	0.68	2.39
Dendritic Cells - plasmacytoid, donor2	11309-117C4	43.09	15.67	0.00	0.00	0.00	0.00	0.00	0.00	1.96	3.26
Dendritic Cells - plasmacytoid, donor3	11385-118B8	43.56	10.16	0.00	0.97	0.00	0.48	0.00	0.00	2.42	2.90
Endothelial Cells - Aortic, donor0	11207-116A1	23.18	18.18	1.17	3.50	1.00	0.17	0.33	0.50	0.50	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	5.28	0.59	1.76	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	20.36	13.57	3.39	2.26	0.85	0.28	0.28	0.85	0.57	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	16.51	15.73	1.18	0.79	0.79	0.00	0.79	1.18	0.00	1.18
Endothelial Cells - Artery, donor1	11264-116G4	13.67	13.38	2.04	2.91	0.29	0.87	0.29	0.00	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	13.65	16.47	5.41	4.94	0.71	0.00	0.24	0.94	0.47	0.94
Endothelial Cells - Artery, donor3	11413-118E9	14.55	20.16	1.05	2.28	1.23	0.53	0.18	0.18	0.35	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	27.26	18.62	0.89	2.22	0.89	0.66	0.22	0.66	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.17	24.95	2.74	3.04	2.13	0.30	1.22	1.22	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	35.52	42.57	5.64	7.05	0.28	2.26	0.28	0.85	0.00	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	21.10	15.75	3.57	5.35	2.08	0.89	0.59	0.89	0.00	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	13.02	6.77	1.04	1.04	0.52	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	35.73	37.72	7.37	6.52	2.41	1.84	1.56	1.42	0.28	2.41
Endothelial Cells - Thoracic, donor1	11266-116G6	8.40	8.40	2.80	2.40	2.00	1.20	0.00	0.00	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	16.77	4.72	4.19	1.57	1.05	0.00	0.00	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	23.11	10.44	2.98	2.98	0.75	1.12	0.12	0.75	0.25	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.95	7.82	1.74	1.30	0.22	0.00	0.22	0.65	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	22.23	11.60	0.98	1.34	1.47	0.12	0.12	0.49	0.37	0.37
Endothelial Cells - Vein, donor1	11267-116G7	18.20	13.65	2.28	1.14	0.00	0.00	0.00	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	17.46	14.67	0.70	2.10	0.70	0.70	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	21.20	18.68	1.88	2.98	1.41	0.63	0.63	0.31	0.16	1.26
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	19.80	4.95	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	35.67	17.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	0.98	0.24	0.00	0.00	0.00	0.00	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.70	15.60	11.08	2.46	1.64	2.87	0.00	0.41	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.87	9.20	7.55	5.15	0.77	0.99	0.44	0.33	0.44	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.64	6.72	10.40	5.20	0.76	0.65	0.00	0.33	0.11	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.86	12.01	4.37	3.40	0.36	1.21	0.24	0.36	0.61	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.01	8.73	1.50	1.77	0.55	0.00	0.68	0.55	0.41	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.23	5.17	4.11	3.06	0.32	0.21	0.00	0.11	0.42	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	9.75	1.58	1.32	1.58	0.00	0.53	0.79	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.95	4.98	2.66	4.98	0.00	0.33	0.33	0.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	59.88	88.46	10.89	14.52	2.27	3.18	1.36	0.91	3.18	1.36
Fibroblast - Cardiac, donor2	11345-117G4	22.74	14.40	2.27	6.06	0.76	0.00	0.00	0.00	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	25.39	28.70	3.94	3.79	1.73	2.21	0.47	0.47	0.63	0.95
Fibroblast - Cardiac, donor4	11452-119A3	34.55	31.22	1.52	3.03	2.73	2.42	3.03	0.00	1.21	1.52
Fibroblast - Cardiac, donor5	11456-119A7	8.50	5.96	1.40	1.02	0.38	0.51	0.25	0.25	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	10.61	5.00	0.76	1.36	0.61	0.91	0.30	0.15	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.08	10.05	1.74	2.01	0.54	0.67	0.54	0.00	0.67	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	2.16	2.16	1.29	0.00	0.43	0.00	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	21.97	0.00	7.32	2.93	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	19.37	3.69	0.23	0.69	0.23	0.00	0.00	0.23	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	34.43	24.25	7.46	6.44	1.53	1.53	0.34	1.19	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	0.94	0.23	0.00	0.47	0.23	0.00	0.00	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	3.77	2.83	0.00	0.47	0.00	0.47	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	1.57	0.36	0.85	0.12	0.12	0.00	0.00	0.00	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	3.84	0.68	0.11	0.23	0.00	0.11	0.11	0.00	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	3.84	0.35	0.00	0.52	0.00	0.17	0.17	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	3.09	1.79	0.16	0.00	0.32	0.00	0.00	0.00	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	6.66	2.50	0.62	1.04	0.83	0.21	0.62	0.42	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	36.94	28.30	12.05	18.86	2.88	2.10	2.10	1.83	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	15.81	6.06	4.48	2.50	1.05	0.40	0.13	0.26	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	14.31	6.96	0.77	1.55	1.16	0.48	0.39	0.39	0.58	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	8.31	6.23	0.00	0.00	0.00	0.00	0.00	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	6.87	4.05	1.94	2.11	0.35	0.35	0.00	0.00	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.54	14.34	6.24	5.30	1.09	1.40	0.47	0.62	0.62	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	6.49	2.98	1.89	2.03	0.41	0.81	0.27	0.41	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.47	11.65	0.00	1.76	1.06	0.00	0.71	0.35	1.06	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	5.70	1.75	2.19	1.61	0.29	0.73	0.15	0.00	0.15	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.86	14.73	15.95	11.04	1.23	1.23	0.14	1.09	0.68	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	5.16	1.21	2.63	1.76	0.44	0.22	0.11	0.11	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	20.54	10.27	10.42	7.19	1.03	1.17	0.15	0.44	0.29	0.59
Fibroblast - Lung, donor1	11270-116H1	21.75	8.16	0.00	0.00	1.36	1.36	1.36	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	4.48	2.98	4.48	1.49	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	24.48	8.02	3.80	2.32	0.42	0.84	0.63	0.21	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	123.29	94.13	4.17	12.50	6.66	7.50	5.83	4.17	3.33	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	34.97	34.97	2.80	11.19	2.80	1.40	1.40	1.40	1.40	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	43.38	30.23	2.80	4.48	2.24	1.12	0.84	1.68	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	17.46	3.65	0.00	0.81	1.22	0.00	0.00	0.81	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	23.97	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	17.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	16.88	5.63	1.36	1.75	1.55	0.19	0.19	0.00	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	18.81	4.85	3.79	3.19	1.06	1.06	0.15	0.30	0.61	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	21.42	11.93	0.31	1.22	1.53	0.00	0.00	0.61	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	7.25	3.05	1.14	0.76	0.38	0.76	0.38	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	5.67	4.32	1.35	2.16	0.54	0.00	0.00	0.27	0.27	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	8.12	7.65	1.51	0.93	0.58	0.35	0.12	0.23	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.90	11.38	3.65	2.98	1.33	0.44	0.66	0.55	0.99	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	41.86	16.66	2.03	3.05	3.05	1.83	1.83	1.42	1.83	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.93	0.40	0.40	0.00	0.00	0.00	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1.98	0.99	0.40	0.40	0.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.95	6.93	1.95	1.42	0.36	0.36	0.18	0.00	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	18.33	10.05	5.32	4.93	0.99	0.20	0.79	0.00	0.59	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	4.32	0.76	0.76	1.30	0.00	0.11	0.22	0.11	0.32	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.30	3.04	1.77	0.51	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	9.68	6.56	4.43	3.94	1.80	0.33	0.82	0.33	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1.60	0.60	0.40	0.60	0.20	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	1.91	0.40	0.40	0.30	0.00	0.10	0.00	0.20	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	3.32	1.21	1.51	0.30	0.00	0.00	0.00	0.00	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	17.56	9.61	2.82	2.65	0.58	0.75	0.08	0.41	0.25	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	29.23	17.78	7.35	11.80	0.68	2.22	0.34	1.03	0.34	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	0.99	0.00	0.33	0.33	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	2.13	0.75	0.53	0.32	0.43	0.11	0.00	0.00	0.11	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	10.63	4.05	3.88	1.69	0.17	0.17	0.51	0.34	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.70	1.10	8.94	5.33	0.16	0.47	0.16	0.00	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	2.61	0.00	1.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.88	2.08	0.69	1.56	1.21	0.35	0.69	0.17	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	4.16	1.04	0.00	0.26	0.78	0.00	0.00	0.52	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	3.58	0.26	0.00	0.26	0.00	0.00	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	29.09	7.66	4.59	3.83	0.00	0.77	0.00	0.00	2.30	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	21.06	9.57	7.66	3.19	0.00	0.64	0.00	0.00	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	9.13	1.71	4.85	2.85	0.57	0.00	0.29	0.00	0.86	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	112.23	22.06	51.57	30.61	3.03	2.48	0.00	0.55	3.86	7.17
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	26.03	3.20	8.68	5.94	0.68	0.46	0.46	0.23	0.46	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.78	3.76	10.10	5.35	1.19	1.59	0.00	0.00	0.40	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	104.94	21.68	51.28	28.55	1.32	2.64	1.06	0.53	5.82	6.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	21.53	3.26	5.54	2.61	0.65	0.00	0.33	0.00	1.30	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.54	1.77	7.08	3.10	0.00	0.00	0.00	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.35	5.94	3.11	4.38	0.42	0.85	0.14	0.00	0.71	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.75	6.90	5.30	5.17	0.74	0.74	0.00	0.37	2.22	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	21.76	7.25	5.10	8.86	0.81	0.81	0.54	0.54	1.88	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.14	13.50	8.18	7.81	0.37	1.12	0.25	0.00	1.73	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	37.51	10.94	6.09	6.23	0.28	1.38	0.00	0.00	0.83	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	30.09	6.91	11.38	7.52	0.41	1.42	0.00	0.00	1.83	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	36.51	13.69	6.62	5.48	0.68	0.68	0.23	0.23	1.37	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	37.49	15.32	8.60	6.85	0.62	1.12	0.25	0.12	0.75	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	29.51	9.84	5.46	5.46	0.66	0.44	0.00	0.00	0.44	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	34.28	10.64	2.95	6.50	1.18	0.89	0.00	0.30	1.77	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.79	10.81	7.79	6.52	0.32	1.43	0.32	0.32	1.11	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	37.98	13.85	5.36	4.02	0.45	1.34	0.00	0.22	0.67	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	36.70	8.87	10.08	6.05	0.81	0.81	0.20	0.20	0.81	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	26.46	10.01	6.11	4.75	0.51	0.68	0.17	0.17	0.68	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	37.06	14.10	3.64	5.23	1.06	0.62	0.44	0.27	0.62	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.05	19.98	8.12	11.97	1.04	0.94	0.21	0.52	1.98	2.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	55.50	20.32	4.61	7.17	0.68	0.68	0.51	0.51	2.05	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	28.88	9.63	5.42	2.88	0.22	0.55	0.11	0.00	1.00	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.70	10.57	3.74	3.83	0.75	1.08	0.25	0.08	0.67	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.73	9.60	2.86	3.27	0.61	0.41	0.41	0.00	0.61	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	41.47	8.05	4.95	6.60	0.62	0.62	0.41	0.21	0.62	2.06
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.28	11.30	8.30	5.53	0.46	1.04	0.00	0.00	0.23	1.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.19	11.67	8.17	5.50	0.67	1.00	0.00	0.33	1.67	1.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	43.65	9.70	6.17	4.41	0.44	1.32	0.00	0.00	1.54	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.37	8.98	6.15	5.41	0.49	0.61	0.25	0.12	1.11	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	30.80	11.67	5.35	3.73	0.49	0.81	0.00	0.49	1.30	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.00	11.23	7.06	5.77	0.32	0.64	0.00	0.00	1.60	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	31.08	7.77	5.21	3.88	0.57	0.38	0.09	0.19	0.95	1.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	32.74	11.55	6.17	4.11	0.95	0.79	0.16	0.00	0.95	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	28.28	8.82	7.60	7.30	0.30	1.22	0.00	0.00	1.22	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.02	8.57	5.12	3.55	0.31	0.42	0.10	0.10	1.05	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	26.13	7.90	4.83	4.39	0.22	0.88	0.00	0.44	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	27.77	6.45	4.49	2.24	0.84	1.12	0.00	0.28	1.40	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	22.68	9.81	1.67	2.69	0.28	0.28	0.19	0.28	0.37	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.99	5.08	3.48	1.87	0.80	0.53	0.00	0.00	1.34	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	26.47	8.87	4.28	3.83	0.92	0.61	0.00	0.15	0.77	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.47	7.64	3.24	1.81	0.78	0.39	0.39	0.52	0.52	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	23.31	7.32	0.81	1.36	0.54	1.08	0.00	0.00	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	30.05	9.77	7.93	3.32	0.18	0.37	0.18	0.55	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	30.92	9.43	6.80	5.92	1.54	1.32	0.88	0.22	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	60.50	23.80	3.97	5.95	0.00	0.00	0.00	0.99	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	28.23	10.29	4.49	3.69	1.19	1.06	0.26	0.26	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.81	7.26	3.23	1.82	0.40	0.20	0.20	0.20	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	103.44	45.24	3.30	12.20	1.52	1.02	0.25	0.76	3.56	5.59
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.75	3.78	2.39	2.59	0.00	1.00	0.00	0.20	1.99	3.18
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	22.03	5.55	5.39	4.31	0.46	0.77	0.46	0.31	2.31	2.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	19.44	3.89	4.09	3.48	0.20	0.00	0.41	0.00	2.25	4.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.42	8.76	3.44	3.13	0.31	1.25	0.00	0.00	3.13	5.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	22.89	6.22	1.41	1.70	0.00	0.28	0.00	0.00	2.26	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.22	4.61	16.14	12.45	0.00	1.84	0.00	0.00	2.77	3.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	9.90	14.85	14.85	0.00	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	30.94	11.99	10.06	7.35	0.00	1.93	0.00	0.00	2.32	4.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	6.42	12.84	6.42	0.00	0.00	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	24.34	5.22	8.69	0.00	1.74	0.00	0.00	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	32.22	10.09	10.42	7.16	0.00	1.30	0.00	0.33	2.28	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	23.88	11.12	19.77	14.41	0.82	1.24	0.00	0.00	1.24	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	10.00	93.30	43.32	0.00	3.33	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.36	10.63	14.54	7.27	0.00	1.68	0.00	0.00	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	30.40	11.44	17.98	13.40	0.33	1.63	0.00	0.00	1.63	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.97	15.10	49.49	23.49	1.68	1.68	0.00	0.00	5.87	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.67	13.68	12.72	6.04	0.32	1.59	0.00	0.00	2.54	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	37.36	16.64	15.62	9.17	0.68	1.70	0.00	0.34	2.04	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	48.03	14.62	4.18	2.09	0.00	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	31.50	13.17	10.88	8.59	0.00	2.29	0.00	0.00	1.72	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	33.74	16.87	15.10	10.66	0.00	1.78	0.00	0.30	2.37	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	25.41	11.86	8.47	13.55	0.00	1.69	0.00	0.00	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	28.17	17.81	10.77	9.53	0.41	4.14	0.00	0.00	1.66	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.45	15.88	11.97	11.97	0.23	2.30	0.00	0.46	2.07	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	36.88	0.00	15.81	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	22.30	11.53	5.38	5.38	0.00	1.15	0.00	0.00	2.31	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.43	9.78	6.52	4.56	0.00	0.98	0.00	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	21.40	7.36	3.34	2.68	0.00	0.00	0.00	0.00	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.97	10.40	9.63	8.86	0.00	1.93	0.00	0.77	1.93	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.63	15.75	19.51	10.27	0.00	1.03	0.34	0.00	1.37	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	24.85	22.36	7.45	0.00	0.00	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	33.50	4.72	12.27	5.66	0.00	1.42	0.47	0.00	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	21.73	7.85	24.14	12.07	0.60	1.21	0.00	0.00	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	26.96	10.68	5.60	4.58	0.00	0.51	0.00	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.12	9.57	9.97	6.78	0.00	1.20	0.00	0.00	1.20	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.65	5.43	7.89	2.96	0.49	0.49	0.00	0.00	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	18.89	10.62	11.80	5.90	0.00	1.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	25.09	5.83	6.42	5.25	0.00	1.17	0.00	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.94	6.58	3.07	2.63	0.00	1.76	0.00	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.95	5.09	16.95	10.17	0.00	0.00	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.26	9.55	9.55	8.95	0.00	0.60	0.00	0.00	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	11.65	4.85	5.34	5.34	0.49	1.94	0.00	0.00	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	12.55	5.71	5.71	0.00	1.14	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	33.27	49.07	20.38	16.22	2.49	2.08	0.83	0.42	2.49	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	14.62	0.00	1.12	1.12	2.25	1.12	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	0.95	2.54	2.85	1.59	0.32	0.00	0.63	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.34	1.67	0.42	0.42	0.00	0.42	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	2.44	1.16	0.81	0.81	0.35	0.35	0.12	0.23	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.87	0.84	0.68	0.17	0.00	0.17	0.17	0.34	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.73	0.68	0.68	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	2.51	0.77	0.44	0.87	0.44	0.33	0.11	0.33	0.11	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	1.50	0.64	0.64	0.21	0.21	0.00	0.21	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	2.58	1.72	0.86	1.08	0.22	0.22	0.65	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1.62	0.87	0.25	0.37	0.50	0.00	0.12	0.25	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	1.54	1.03	0.17	0.34	0.00	0.00	0.34	0.51	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1.92	0.32	0.32	0.00	0.00	0.32	0.00	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	27.42	34.14	3.36	8.39	3.36	4.48	1.12	0.00	0.56	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	56.26	30.30	1.73	2.60	1.73	1.30	0.87	1.30	3.03	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	2.64	18.51	13.22	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	64.55	53.26	8.47	11.99	2.12	1.06	0.71	2.12	2.47	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	47.22	34.15	10.17	10.90	2.91	1.45	1.45	0.00	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	15.39	5.59	6.82	3.67	0.17	0.35	0.00	0.35	0.17	0.35
Hepatocyte, donor1	11523-119I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	0.00	0.00	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	7.98	1.23	9.82	1.84	1.23	0.00	0.00	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	13.63	4.89	1.22	2.27	0.35	0.70	0.87	0.87	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.39	0.69	0.96	0.55	0.00	0.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.15	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	1.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	1.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.42	0.94	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	0.00	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.28	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.23	0.31	0.00	0.31	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	0.87	0.00	0.00	0.00	0.00	0.00	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	19.18	11.42	4.49	6.20	4.49	0.90	4.57	3.35	0.41	0.49
Keratinocyte - epidermal, donor2	11349-117G8	2.34	2.34	1.76	0.00	0.59	0.00	1.76	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	46.95	25.94	21.49	12.87	5.40	2.08	0.85	3.03	1.23	0.00
Keratinocyte - oral, donor1	11251-116E9	15.21	2.61	1.82	2.04	0.91	0.57	0.45	0.57	0.23	0.23
Keratocytes, donor1	11527-119I6	13.75	2.41	1.38	1.72	1.03	0.00	0.00	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	8.20	1.17	1.17	0.00	0.00	0.00	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	11.07	2.77	2.96	1.58	0.99	0.20	0.20	0.00	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	6.59	0.00	0.00	0.00	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	4.31	0.00	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	12.80	4.84	2.08	1.85	0.46	0.12	0.12	0.12	0.12	0.46
Lens Epithelial Cells, donor3	11690-122I7	4.54	1.01	0.10	0.30	0.10	0.10	0.00	0.00	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9.25	3.79	1.19	1.07	0.36	0.59	0.36	0.00	0.47	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.02	2.79	1.95	1.12	0.00	0.00	0.28	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.04	2.05	4.56	2.20	0.79	0.79	0.00	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	1.61	2.69	1.61	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	2.21	5.67	5.04	0.63	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.12	2.05	4.42	2.05	0.43	0.22	0.11	0.32	0.22	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.92	0.82	2.87	1.64	0.41	0.00	0.41	0.41	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.84	3.29	1.26	1.26	1.01	0.25	0.51	0.00	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.33	2.11	4.79	3.10	0.00	0.84	0.42	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	4.75	1.98	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.62	2.13	2.52	0.78	0.39	0.00	0.19	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.30	3.89	1.67	2.22	0.37	0.37	0.00	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	3.14	2.44	1.39	3.14	0.35	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.11	2.62	2.86	1.43	0.24	0.00	0.72	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.63	2.06	3.30	3.16	0.14	0.27	0.14	0.14	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	4.31	1.54	1.54	2.16	0.31	0.31	0.00	0.62	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.79	1.87	1.56	1.87	0.31	0.62	0.00	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.95	2.20	3.66	2.74	0.18	0.00	0.00	0.37	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	2.30	0.66	1.65	0.00	0.66	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.74	1.76	2.34	3.22	0.29	0.29	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.98	1.74	3.73	1.49	0.25	0.25	0.00	0.50	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.27	0.97	2.91	0.48	0.00	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.19	3.23	1.62	0.81	0.27	0.27	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4.84	2.27	2.12	2.57	0.30	0.15	0.15	0.00	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.11	2.59	2.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.70	1.26	1.05	1.26	0.42	0.00	0.42	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.52	1.95	1.50	1.50	0.15	0.15	0.15	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.13	1.38	1.38	1.38	1.38	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.27	2.63	2.07	0.38	0.75	0.00	0.00	0.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.10	1.70	2.97	2.01	0.11	1.27	0.11	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.36	2.91	0.48	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	0.33	0.99	0.99	0.33	0.00	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.04	2.60	5.58	4.09	0.12	0.12	0.00	0.12	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6.29	2.59	2.96	0.37	0.00	0.74	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.69	1.48	0.74	0.74	0.00	0.00	0.00	0.25	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.46	2.47	2.89	2.47	0.41	0.41	0.14	0.41	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	5.79	1.29	2.89	1.61	0.32	0.64	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	4.87	1.52	1.22	1.22	0.30	0.30	0.00	0.30	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.86	1.40	2.52	1.68	0.56	0.00	0.00	0.28	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.24	3.20	2.13	1.78	1.07	0.00	0.36	0.71	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	0.97	1.45	1.45	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.54	2.65	2.80	2.18	0.31	0.62	0.00	0.16	0.31	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.01	1.07	2.86	1.43	1.43	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.53	0.98	0.33	0.98	0.33	0.65	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.12	2.12	3.06	1.18	0.47	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.29	3.59	2.23	1.98	0.74	1.11	0.25	0.62	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.40	1.54	1.54	1.28	0.00	0.26	0.51	0.51	0.00	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.97	1.49	3.58	1.79	0.30	0.60	0.00	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	11.33	0.00	0.00	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	13.04	2.30	3.84	0.00	0.77	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	12.62	16.33	3.71	2.23	0.00	0.74	0.74	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	16.93	9.73	6.35	5.08	0.85	0.00	0.00	0.85	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	20.40	9.85	6.33	7.03	0.00	1.41	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	18.68	6.54	6.54	2.80	0.00	0.93	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.88	6.18	5.15	6.18	0.00	3.09	0.00	1.03	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	5.95	2.38	2.38	1.19	1.19	0.00	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.13	14.02	1.36	1.81	1.36	0.68	1.13	0.90	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.51	9.60	7.56	5.82	1.16	1.45	0.29	0.00	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.31	8.55	7.65	6.30	0.00	0.00	0.45	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.93	18.56	2.98	3.25	0.81	1.22	1.22	1.35	0.41	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	15.92	10.78	5.65	5.65	0.00	1.03	1.03	0.51	0.00	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	10.94	3.88	4.23	0.35	1.06	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	10.66	9.33	3.33	2.67	0.67	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	17.32	9.17	7.64	6.11	0.00	0.51	0.51	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.21	13.07	6.40	4.80	0.00	1.33	0.53	0.80	0.27	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	14.36	7.37	7.18	5.67	0.57	0.94	1.13	0.94	0.38	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.95	8.59	7.98	7.98	0.61	1.84	2.45	0.00	1.23	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	14.68	13.05	9.79	4.08	0.82	0.00	0.82	0.82	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	17.70	8.33	9.37	7.29	1.25	1.87	0.62	0.62	1.04	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.93	8.69	10.93	4.76	0.84	1.12	0.28	1.12	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	14.42	16.49	4.12	5.15	1.03	0.00	2.06	1.03	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.22	11.90	8.71	7.26	0.58	0.29	1.16	0.58	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	8.07	8.07	5.08	0.60	1.20	0.30	0.30	0.00	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	17.15	7.19	3.87	4.98	0.00	0.55	1.11	1.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	20.86	13.08	7.42	10.60	0.35	0.00	1.41	0.00	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.75	10.69	6.27	7.01	0.74	0.37	0.37	1.11	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	11.51	6.91	3.45	0.00	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.97	11.90	6.52	6.52	1.54	0.77	0.38	0.00	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.85	9.62	6.23	10.76	1.13	4.53	0.00	0.57	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.95	7.38	3.28	5.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	22.14	13.56	7.23	4.97	0.45	0.90	0.90	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	11.49	15.80	12.21	7.18	0.72	0.72	0.00	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.90	4.48	3.73	4.48	0.00	0.75	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.07	13.75	10.03	14.12	0.74	3.72	1.11	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.77	6.89	3.02	5.60	1.29	0.43	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	6.85	5.14	8.56	0.00	1.71	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.99	11.33	7.66	6.66	0.33	3.33	1.00	0.67	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.29	9.65	7.24	6.64	0.00	1.81	1.21	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	22.04	14.22	4.98	3.55	1.42	0.71	0.71	0.00	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.97	9.62	6.53	6.19	1.37	1.03	0.69	0.69	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.42	12.88	10.20	6.98	1.07	0.00	0.00	0.54	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.81	7.41	5.39	1.35	0.00	0.67	0.67	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.04	14.82	7.04	12.59	0.37	1.48	1.11	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	1.16	1.16	0.00	0.00	1.16	2.33	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	8.46	3.17	2.12	1.06	2.12	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	20.41	13.20	8.40	7.60	1.20	2.00	0.40	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	12.36	7.27	2.18	5.81	1.45	0.73	0.73	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	17.63	8.43	3.07	6.13	0.77	1.53	0.00	0.77	0.77	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	7.40	6.41	2.96	1.48	2.47	0.49	0.00	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	7.53	8.47	8.47	0.00	0.94	1.88	1.88	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	16.09	15.08	1.01	2.51	0.50	0.00	3.02	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.02	10.81	10.36	7.66	0.90	1.80	2.70	0.90	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	5.16	6.88	6.88	1.72	1.72	1.72	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	18.26	12.91	4.45	8.46	0.89	1.34	0.89	1.34	0.00	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	19.16	12.12	5.87	8.60	0.78	1.17	0.78	1.17	0.78	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	12.53	7.92	3.30	5.94	0.00	1.32	0.66	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	19.72	14.53	5.71	7.26	0.52	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.19	10.94	10.94	14.00	0.44	2.19	0.88	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.62	8.39	5.03	3.91	0.56	1.68	1.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	21.64	10.16	5.74	3.09	0.88	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.89	13.11	6.56	3.86	0.00	0.39	0.39	0.77	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.15	7.60	7.09	3.04	0.51	0.51	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.02	14.42	5.77	4.81	0.48	0.48	0.96	0.96	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	18.29	10.73	5.57	5.17	0.40	1.99	0.40	1.19	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	19.44	9.72	10.33	4.86	0.00	0.00	1.22	1.22	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.14	4.15	4.15	2.77	0.00	1.38	0.00	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.86	13.30	5.70	9.50	0.00	1.14	0.76	1.52	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.30	6.20	10.84	8.78	0.52	0.52	1.55	0.00	0.00	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.70	9.07	2.42	9.07	0.00	0.00	0.60	0.60	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	17.43	13.94	7.61	6.02	0.95	1.90	0.95	0.32	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.39	8.00	3.20	2.67	1.07	1.07	1.07	1.60	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	8.62	2.30	2.87	0.57	0.00	0.57	0.57	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	23.14	9.77	10.80	8.23	0.51	1.03	0.00	1.03	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	13.44	13.44	5.66	7.78	0.00	2.83	3.54	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.16	9.65	4.54	7.38	0.00	0.57	0.57	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	20.39	15.39	6.66	5.41	0.83	2.50	1.25	0.83	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	9.40	8.61	10.18	0.78	0.00	1.57	1.57	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	20.46	6.68	4.18	7.52	1.25	1.25	0.42	0.42	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	24.16	12.55	8.36	5.11	0.93	0.46	1.39	1.39	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	14.72	4.01	7.36	0.67	2.68	0.67	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.11	9.62	5.35	7.48	0.53	0.53	1.07	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.78	10.51	7.68	10.51	0.81	2.02	1.21	0.81	0.81	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	12.85	5.51	5.51	3.67	0.00	1.84	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.00	11.56	6.22	10.67	0.00	0.89	0.00	0.00	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	25.07	14.82	2.28	3.42	2.28	1.14	0.57	0.57	0.57	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	12.27	9.20	4.60	0.77	0.77	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.68	6.02	4.38	9.85	1.09	1.09	0.00	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	25.39	12.47	6.24	5.35	0.00	0.89	0.00	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.00	14.30	2.34	2.08	1.30	0.52	0.78	0.78	1.04	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	12.60	5.97	5.30	2.65	0.00	0.66	0.66	1.33	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	16.63	4.16	12.47	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	15.50	2.28	1.60	0.68	0.91	0.23	0.23	0.23	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	20.37	6.61	1.28	2.20	0.55	0.18	0.37	0.00	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	23.07	9.96	3.28	1.97	1.97	0.52	0.52	0.79	0.66	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	7.76	2.54	3.01	3.64	1.74	0.32	0.95	0.95	0.32	0.32
Mallassez-derived cells, donor3	11930-125I4	0.00	0.00	0.14	0.14	0.00	0.00	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	7.87	2.19	3.89	3.69	0.90	0.20	1.10	1.49	0.20	0.30
Mammary Epithelial Cell, donor2	11350-117G9	4.63	4.05	2.03	2.61	2.03	0.58	2.32	2.90	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	8.98	4.49	1.25	0.50	1.50	0.50	0.25	2.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	8.14	0.68	0.68	4.75	0.00	1.36	0.00	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	4.54	0.43	0.54	0.76	0.00	0.22	0.00	0.11	0.00	0.00
Mast cell, donor2	11565-120D8	75.19	29.12	22.88	17.53	4.16	0.89	2.38	2.38	0.89	0.89
Mast cell, donor3	11566-120D9	102.43	41.42	6.53	11.48	3.38	1.58	1.13	2.03	1.58	2.48
Mast cell, donor4	11567-120E1	63.11	20.57	4.08	6.56	3.90	0.18	0.53	0.71	0.89	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	7.54	1.11	2.00	1.33	0.00	0.11	0.22	0.00	0.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	4.09	1.75	1.17	1.75	0.58	0.00	0.00	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	4.36	0.34	0.23	0.69	0.00	0.23	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	3.01	0.67	0.17	0.00	0.17	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	11.54	4.38	1.79	0.40	0.40	0.30	0.20	0.10	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	15.23	7.27	4.50	2.42	0.00	0.35	0.35	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	19.12	4.85	2.97	1.67	0.72	0.51	0.14	0.72	0.29	0.29
Melanocyte - light, donor1	11274-116H5	15.28	4.94	0.47	2.12	0.94	0.71	0.47	0.47	0.24	0.24
Melanocyte - light, donor2	11351-117H1	9.55	4.09	0.00	0.00	0.00	0.00	0.00	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	10.41	6.07	0.87	0.87	0.87	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	7.71	1.15	0.83	0.52	0.31	0.10	0.21	0.21	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	6.16	2.41	1.07	1.07	0.27	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	21.83	8.06	0.62	1.49	0.25	0.74	0.00	0.50	0.74	0.12
Meningeal Cells, donor2	11573-120E7	6.60	3.52	0.00	0.88	0.00	1.32	0.00	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	18.83	3.18	1.96	2.36	0.24	0.90	0.24	0.00	0.49	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	2.57	0.00	0.00	0.29	0.57	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.23	2.42	0.60	1.31	0.30	0.10	0.00	0.00	0.20	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	31.54	23.65	1.31	2.63	2.63	0.00	0.00	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	1.31	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	9.33	5.02	3.59	1.44	0.00	0.00	0.72	0.00	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.85	8.89	6.56	5.72	0.64	0.64	0.21	0.42	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.04	5.03	3.02	4.02	0.50	1.01	0.00	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.57	2.86	0.66	0.66	0.22	0.22	0.00	0.44	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	0.00	0.73	0.73	2.19	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1.64	1.23	0.41	0.00	0.00	0.20	0.20	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	16.34	9.97	3.19	2.77	0.14	0.83	0.28	0.83	0.00	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	49.07	39.03	6.69	7.06	1.49	2.23	1.12	0.74	1.49	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	47.24	40.26	25.00	18.29	1.71	3.16	0.26	0.79	1.05	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1.19	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1.92	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	5.32	6.73	0.71	1.77	0.00	0.00	0.00	0.00	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	46.91	24.39	7.19	6.88	1.88	1.25	0.94	0.31	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.18	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	29.70	24.66	4.51	3.71	0.80	2.39	1.33	1.86	1.06	1.59
Mesothelial Cells, donor2	12156-128G5	45.04	74.57	7.01	9.01	0.50	2.50	2.50	1.50	1.00	2.50
Mesothelial Cells, donor3	11402-118D7	25.87	18.86	7.37	7.73	2.31	1.45	1.08	1.01	0.51	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	24.31	2.70	1.35	0.00	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	13.55	3.45	1.97	3.94	0.25	0.25	0.00	0.00	0.99	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.61	5.59	1.77	2.06	0.59	0.29	0.00	0.29	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.99	4.34	0.62	1.55	0.00	0.31	0.00	0.31	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.94	4.56	3.94	1.45	0.21	0.62	0.00	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	2.32	2.32	0.00	4.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.02	5.26	2.50	2.50	0.25	0.00	0.75	0.00	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	17.22	6.05	0.00	2.33	0.47	0.47	0.00	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	16.87	4.47	2.44	2.64	0.41	0.81	0.00	0.00	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.05	5.54	3.56	1.19	0.40	0.00	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	4.42	2.65	0.88	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.16	3.42	1.90	3.80	0.38	1.14	0.00	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	2.63	0.00	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.61	2.55	2.33	2.55	0.21	0.21	0.00	0.00	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	2.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.73	1.79	1.49	2.09	0.30	0.30	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	10.06	0.00	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.28	3.01	0.75	2.76	0.00	0.25	0.50	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.02	3.80	3.33	2.38	0.71	0.24	0.24	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.61	1.66	0.00	0.55	0.55	0.00	0.00	0.00	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.28	2.76	1.61	2.07	0.00	0.00	0.00	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	14.93	4.84	0.84	1.47	0.42	0.21	0.21	0.63	0.21	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.17	2.65	1.43	1.22	0.41	0.20	0.00	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.16	3.00	1.07	1.72	0.00	0.21	0.00	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.78	3.11	1.33	1.11	1.33	0.22	0.00	0.00	0.89	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.32	3.72	3.07	0.66	0.00	0.22	0.00	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.15	1.52	0.00	0.00	0.00	0.00	0.51	0.00	1.52	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.60	3.26	1.36	0.27	0.00	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.35	5.29	2.06	0.29	0.00	0.00	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	5.45	1.09	3.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	5.29	0.48	1.44	0.48	0.00	0.00	0.00	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.61	2.40	0.80	1.20	0.00	0.40	0.00	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	3.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.26	0.44	0.00	2.19	0.00	0.44	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	3.31	1.10	0.00	0.00	0.00	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	3.84	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	8.18	2.73	0.74	1.98	0.00	0.25	0.00	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	3.48	0.70	0.00	0.70	0.00	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.57	3.08	4.10	1.71	0.00	0.34	0.00	0.00	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	3.50	0.00	0.44	0.00	0.00	0.00	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.46	1.78	0.00	0.71	0.00	0.00	0.00	0.00	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	7.01	3.37	0.84	1.12	0.00	0.28	0.28	0.00	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.74	2.08	0.42	0.42	0.42	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	7.58	1.17	0.00	0.58	0.58	0.00	0.00	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.24	1.81	1.21	1.21	0.00	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.68	0.00	2.09	0.83	0.00	0.00	0.00	0.00	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	1.85	0.92	0.00	0.00	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	3.41	2.28	0.00	0.00	0.00	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.32	1.66	0.14	0.83	0.28	0.00	0.00	0.14	0.55	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.00	2.85	1.55	1.30	0.52	0.00	0.00	0.00	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	8.58	3.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	3.18	0.00	0.64	0.00	0.00	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.27	0.53	0.00	0.80	0.80	0.00	0.00	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	8.68	2.69	0.90	0.30	0.00	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.93	1.84	0.14	0.28	0.14	0.00	0.00	0.00	0.71	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	6.37	2.23	0.32	0.32	0.00	0.32	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	6.19	0.88	0.66	1.33	0.00	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.20	1.90	0.76	0.38	0.00	0.00	0.00	0.00	0.00	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.11	1.14	1.14	0.57	0.28	0.00	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.15	2.21	1.23	0.74	0.25	0.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	1.30	0.00	0.00	0.00	0.00	0.65	0.65	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.35	2.06	0.29	0.29	0.29	0.00	0.00	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.80	2.88	1.15	1.15	0.86	0.00	0.00	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.54	2.06	1.24	2.06	0.00	0.82	0.41	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.15	1.49	0.30	0.00	0.30	0.00	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	0.00	0.00	0.00	0.00	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	10.84	2.63	5.26	2.63	0.00	0.00	0.00	0.00	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	0.00	1.05	0.00	1.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2.57	0.59	0.00	0.00	0.20	0.00	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	10.24	3.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	6.76	3.00	4.88	3.76	0.38	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.79	3.20	0.53	0.80	0.27	0.00	0.27	0.00	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.18	0.57	0.34	0.23	0.11	0.00	0.23	0.23	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	1.47	0.74	2.21	0.74	0.00	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	8.06	3.30	2.56	1.47	0.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	0.00	6.22	1.56	1.56	1.56	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	3.86	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	8.08	4.04	1.01	0.00	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	3.79	2.95	2.95	0.00	0.42	0.00	0.00	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	3.26	0.00	3.26	0.00	0.00	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	4.31	1.51	1.51	0.86	0.22	0.22	0.00	0.22	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	6.79	4.70	1.57	4.18	0.00	0.00	0.00	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	7.34	2.67	0.67	0.67	0.67	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.09	0.42	0.42	0.83	0.83	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	3.42	0.38	5.70	2.85	0.57	0.00	0.19	0.19	0.19	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	14.36	1.60	1.60	1.60	0.00	0.00	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	1.36	0.68	0.00	0.68	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	0.00	9.19	3.68	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.86	1.26	1.26	0.84	0.00	1.26	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.25	1.16	2.09	0.23	0.93	0.00	0.00	0.23	0.23	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.27	3.51	2.16	1.62	0.54	0.00	0.27	0.00	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	5.68	2.73	1.26	0.84	1.05	0.21	0.00	0.00	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	22.27	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	3.97	1.49	1.49	0.00	0.50	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.77	1.35	16.24	4.33	1.08	0.81	0.27	0.27	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.12	1.13	1.59	1.81	0.45	0.45	0.68	0.45	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.04	3.27	2.45	1.96	0.82	0.65	0.49	0.16	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.48	3.10	2.92	1.28	0.73	1.28	0.36	0.00	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	4.24	4.24	1.59	1.59	1.59	1.06	1.06	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	0.60	3.60	1.20	0.00	0.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.27	1.31	28.55	13.13	0.66	0.66	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.13	5.85	3.42	1.46	2.11	1.14	0.49	0.49	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.99	6.88	5.12	3.00	1.06	0.71	0.53	0.71	0.71	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.74	4.92	2.81	2.11	0.70	1.41	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.06	2.30	4.14	1.84	0.00	0.00	0.00	0.92	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.42	10.28	6.11	3.21	2.25	0.96	0.64	0.96	0.32	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.93	4.14	32.42	15.86	1.03	1.72	0.34	0.00	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	2.53	20.23	37.93	0.00	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	11.14	5.35	1.78	2.01	1.34	0.00	0.00	0.45	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.74	3.81	6.35	2.96	0.42	0.85	0.42	0.85	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.65	1.66	6.17	2.85	0.47	0.71	0.24	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.02	9.01	3.86	3.00	1.29	0.86	0.00	1.29	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	117.36	36.11	0.00	18.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.33	4.00	2.67	1.33	0.33	1.67	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.92	9.47	2.25	3.61	0.90	0.45	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.54	1.98	1.98	2.78	0.40	0.79	0.00	0.00	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	3.71	3.71	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	11.35	4.92	10.59	2.27	0.38	1.51	1.51	0.76	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.45	3.26	2.93	1.96	0.65	1.63	0.00	0.65	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.51	6.97	0.87	0.87	1.31	0.00	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.66	6.33	1.81	1.36	0.00	0.45	0.90	0.45	1.81	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	7.06	5.29	1.76	0.00	0.88	0.00	0.88	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	4.65	6.65	1.99	0.66	0.00	0.00	0.00	0.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.37	8.43	7.44	3.97	1.98	2.48	0.50	0.00	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	10.34	3.45	3.06	2.30	1.53	0.38	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	10.59	4.23	7.86	2.72	1.21	1.21	0.60	0.60	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.71	5.75	4.42	2.87	1.33	0.22	0.44	0.22	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	6.10	3.39	2.03	2.03	0.68	0.68	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	61.31	40.88	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	7.32	3.05	1.83	2.44	0.61	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.87	3.46	3.15	1.26	0.63	0.00	0.31	0.63	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.29	7.57	3.93	2.42	1.51	0.91	0.30	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	3.16	6.33	1.58	0.79	2.37	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	10.20	0.00	45.35	14.74	0.00	1.13	0.00	0.00	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	75.87	40.46	0.00	0.00	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	4.72	3.60	1.37	0.87	0.50	0.12	0.50	0.87	0.12	0.25
Myoblast, donor2	11322-117D8	2.11	2.49	1.34	1.53	0.19	0.19	0.19	0.38	0.00	0.00
Myoblast, donor3	11398-118D3	7.90	7.57	0.84	2.19	1.01	1.01	0.17	1.51	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	14.76	3.38	2.77	1.54	0.92	0.62	0.00	0.00	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	17.79	6.63	4.82	4.52	0.00	0.90	0.00	0.00	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	4.42	2.21	2.02	0.55	0.55	0.00	0.00	0.18	0.18	0.37
Neural stem cells, donor1	11275-116H6	20.32	6.53	7.62	10.16	0.73	0.00	0.36	0.36	0.36	0.73
Neural stem cells, donor2	11352-117H2	105.91	26.96	7.70	28.88	0.00	0.00	0.00	0.00	5.78	0.00
Neurons, donor1	11494-119E9	34.14	12.52	12.52	2.28	0.00	1.14	0.00	0.00	2.28	1.14
Neurons, donor2	11574-120E8	43.37	9.47	3.96	4.18	0.00	1.32	0.00	0.00	1.76	1.76
Neurons, donor3	11655-122E8	18.09	3.29	31.24	11.51	0.00	4.11	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	36.19	15.78	12.99	16.70	2.78	2.78	1.86	0.93	0.93	0.00
Neutrophils, donor2	11314-117C9	49.28	14.49	28.99	34.79	2.90	8.70	0.00	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	55.59	31.15	7.94	10.38	4.28	4.28	1.22	2.44	0.61	5.50
Nucleus Pulposus Cell, donor1	11252-116F1	7.84	2.97	1.54	0.71	0.36	0.47	0.59	0.24	0.12	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	1.30	0.98	0.00	0.00	0.00	0.00	0.33	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	2.01	0.60	0.20	0.60	0.00	0.20	0.00	0.00	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	40.06	39.51	103.93	37.58	2.62	4.54	0.83	1.38	0.96	1.38
Olfactory epithelial cells, donor2	11934-125I8	22.15	26.49	57.46	25.48	3.62	7.67	1.30	0.87	1.16	0.72
Olfactory epithelial cells, donor3	11935-125I9	22.02	22.59	39.50	16.12	2.61	3.18	1.59	1.02	0.34	0.11
Olfactory epithelial cells, donor4	11936-126A1	33.50	25.42	21.91	11.79	2.24	2.53	0.78	1.46	0.58	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	29.49	14.44	13.24	5.42	4.81	1.81	1.81	1.81	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	26.37	16.80	1.06	1.91	0.85	0.43	1.91	1.49	0.00	1.06
Osteoblast - differentiated, donor2	11353-117H3	6.86	5.72	8.00	0.00	1.14	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	8.07	5.59	0.62	1.24	1.86	0.62	1.24	0.00	0.00	1.24
Osteoblast, donor1	11277-116H8	6.25	1.56	0.39	0.20	0.39	0.00	0.00	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	5.62	2.11	0.70	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	17.24	6.40	0.71	1.60	0.53	0.18	0.36	0.36	0.53	0.36
Pancreatic stromal cells, donor1	11249-116E7	17.27	6.65	3.20	3.54	1.26	0.34	0.76	0.67	0.84	0.67
Pericytes, donor1	11491-119E6	8.46	2.56	0.11	1.00	0.00	0.33	0.00	0.11	0.22	0.22
Pericytes, donor2	11571-120E5	7.02	3.40	0.91	0.91	1.58	1.13	0.23	0.45	0.23	0.00
Pericytes, donor3	11652-122E5	32.15	20.14	4.88	5.49	1.02	2.24	0.20	1.02	0.61	1.02
Perineurial Cells, donor1	11499-119F5	22.60	5.20	2.03	1.92	0.68	0.68	0.11	0.23	0.57	0.23
Perineurial Cells, donor2	11579-120F4	20.79	9.02	2.39	2.39	0.74	0.46	0.28	0.46	1.01	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	11.79	1.91	0.96	1.91	0.00	0.32	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	4.90	2.94	1.47	1.71	0.98	0.73	0.00	0.00	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.98	4.40	1.29	1.29	0.39	0.13	0.26	0.13	0.13	0.13
Placental Epithelial Cells, donor1	11278-116H9	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	2.55	0.98	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.97	9.81	9.81	6.33	1.27	0.95	0.63	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	24.20	29.83	7.50	11.82	1.69	2.44	1.88	2.06	1.31	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.48	6.40	1.44	1.57	0.65	0.26	0.39	0.26	0.52	0.52
Preadipocyte - breast, donor2	11328-117E5	13.28	14.18	4.05	5.85	1.58	2.25	0.45	1.13	1.13	0.68
Preadipocyte - omental, donor1	11468-119C1	47.74	63.62	23.02	26.96	2.56	3.62	2.98	2.45	1.07	1.92
Preadipocyte - omental, donor2	11329-117E6	24.44	26.62	5.24	13.53	2.18	1.31	1.31	1.31	0.87	1.31
Preadipocyte - omental, donor3	11403-118D8	51.43	72.77	28.22	26.07	2.58	3.01	1.43	2.29	0.86	1.86
Preadipocyte - perirenal, donor1	11469-119C2	42.32	64.96	9.84	4.92	1.97	1.97	1.97	5.91	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	33.48	17.51	0.61	0.92	1.54	0.92	0.92	0.61	1.23	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	29.39	13.99	15.58	13.81	0.89	3.01	0.35	0.35	0.89	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	39.85	25.88	6.81	7.49	1.70	0.68	0.34	0.68	1.36	0.85
Preadipocyte - visceral, donor1	11280-116I2	26.83	15.37	9.69	8.57	1.12	0.93	0.75	0.28	0.56	0.47
Preadipocyte - visceral, donor2	11357-117H7	10.58	1.84	4.60	4.60	0.00	1.38	0.00	0.46	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	14.11	10.24	5.64	3.45	1.15	1.15	0.21	0.52	0.94	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	7.54	1.81	1.21	1.21	0.45	0.45	0.15	0.30	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	5.01	2.71	2.57	2.98	0.81	0.68	1.08	1.22	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	14.33	5.14	9.31	7.29	5.02	0.80	4.96	4.10	0.12	0.06
Prostate Stromal Cells, donor1	11254-116F3	14.35	10.25	3.87	2.96	1.14	0.34	0.34	0.11	0.34	0.57
Prostate Stromal Cells, donor2	11332-117E9	17.03	9.68	8.25	8.07	1.61	2.33	0.18	0.54	0.54	0.00
Prostate Stromal Cells, donor3	11405-118E1	24.19	16.16	5.63	3.86	1.67	1.25	0.63	0.31	0.94	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	15.69	2.55	0.36	1.09	0.36	0.00	0.36	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	10.88	1.59	2.01	1.94	0.62	0.55	0.28	0.21	0.49	0.00
Renal Epithelial Cells, donor1	11517-119H5	14.71	2.54	0.51	2.03	0.51	0.00	0.51	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	2.13	0.71	0.00	0.00	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	9.21	1.69	1.06	0.53	0.21	0.21	0.21	0.21	0.32	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.11	8.17	1.36	2.72	2.04	1.36	2.04	0.68	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.67	10.92	2.83	4.04	0.54	1.08	0.40	0.54	0.81	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.10	5.77	6.44	5.11	0.22	0.22	0.00	0.22	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	34.60	26.62	3.33	5.99	0.00	2.00	0.00	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	11.22	2.42	0.66	1.76	0.00	0.22	0.44	0.00	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	10.66	2.51	0.00	0.63	0.63	0.63	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	18.31	3.05	1.39	0.55	0.28	0.28	0.28	0.28	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	2.15	0.00	0.00	0.00	0.27	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.95	0.84	0.42	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.66	0.77	0.77	0.39	0.19	0.00	0.19	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	8.82	1.30	1.56	1.30	0.52	0.00	0.26	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	11.94	2.56	1.14	0.57	0.28	0.00	0.57	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	0.00	2.06	1.03	0.00	0.00	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	2.51	0.75	0.00	0.50	0.00	0.25	0.25	0.50	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	11.49	6.41	1.87	2.41	0.67	0.80	0.40	0.13	0.13	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	59.86	33.95	19.65	6.25	1.79	0.89	0.00	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.87	18.71	63.84	32.47	1.10	8.81	0.00	0.55	3.30	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	66.71	17.40	63.81	33.06	1.74	6.96	0.58	1.16	2.90	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	9.23	2.73	1.17	2.21	0.13	0.52	0.26	0.00	0.39	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.00	8.54	4.07	3.28	0.70	0.89	0.10	0.20	0.20	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	19.85	7.58	2.01	2.12	0.22	0.56	0.45	0.45	0.22	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	13.40	4.09	4.84	3.60	0.50	0.87	0.12	0.12	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.76	8.27	5.13	4.08	0.93	0.93	0.35	0.35	0.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	21.73	10.86	10.86	7.86	0.00	1.39	0.00	0.69	0.23	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.42	2.46	2.74	2.60	0.27	0.41	0.27	0.00	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.00	5.90	5.14	5.14	0.15	0.45	0.30	0.30	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	19.35	6.27	0.90	0.72	0.36	0.36	0.00	0.18	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.49	4.16	3.59	3.01	0.14	0.29	0.14	0.29	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.60	9.34	3.00	2.79	0.54	1.61	0.54	0.43	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.15	9.96	4.65	2.66	0.44	0.22	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.29	2.29	1.34	1.72	0.57	0.57	0.19	0.19	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.93	7.73	1.96	1.77	0.19	0.28	0.47	0.28	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.92	7.52	9.02	6.76	0.19	0.56	0.00	0.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	13.01	3.58	3.32	1.46	0.13	0.40	0.00	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.64	7.88	2.73	4.09	0.39	0.78	0.10	0.29	0.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.19	9.17	9.55	4.77	0.57	0.38	0.00	0.19	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.36	3.84	1.92	1.71	0.21	0.11	0.11	0.32	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	15.70	8.41	4.20	2.80	1.68	0.84	0.28	0.28	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	15.21	5.98	3.93	2.05	1.20	0.00	0.00	0.17	1.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.39	3.46	0.55	0.55	0.36	0.18	0.00	0.18	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	16.80	7.36	5.27	2.94	0.37	0.98	0.12	0.37	0.74	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	21.22	7.66	3.36	2.55	0.54	0.81	0.27	0.54	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.68	4.01	3.07	4.01	0.47	0.71	0.00	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.45	8.73	6.15	5.16	0.99	0.20	0.00	0.00	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	20.81	11.46	4.44	3.27	0.94	1.17	0.47	0.23	0.94	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	17.42	2.90	1.45	1.45	0.41	0.21	0.21	0.83	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	14.16	6.64	3.76	3.32	0.66	0.88	0.44	0.66	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	16.50	6.48	2.92	1.25	1.04	1.25	0.00	0.63	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	13.32	4.17	2.42	3.23	0.40	0.94	0.13	0.81	0.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	15.67	8.34	1.87	2.38	0.68	0.17	0.17	0.00	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	17.16	8.87	4.24	5.21	0.96	1.35	0.00	0.77	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.04	2.41	2.75	2.58	0.34	0.34	0.00	0.00	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.17	6.72	1.37	0.96	1.23	0.27	0.27	0.55	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.78	6.40	3.94	2.46	0.82	1.15	0.16	0.16	0.82	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	12.95	4.26	2.56	3.24	0.34	0.34	0.17	0.34	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	21.60	8.29	4.44	3.85	0.89	0.74	0.00	0.15	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	20.52	7.73	2.67	2.40	1.87	0.27	0.00	0.27	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	31.11	15.35	6.22	3.73	0.69	1.66	0.28	0.00	1.94	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	32.14	11.43	8.57	6.43	0.95	0.48	0.48	0.24	1.19	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.78	18.34	7.46	6.85	1.01	1.61	0.40	0.40	2.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	33.62	14.60	8.85	7.72	0.57	1.79	0.47	0.57	1.88	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	49.61	33.54	45.07	25.85	2.10	5.59	0.70	0.70	2.45	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	45.94	29.62	15.11	9.67	1.81	1.21	1.21	0.30	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	34.15	16.89	10.28	10.53	0.73	1.84	0.86	0.73	1.10	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	70.30	40.17	7.28	9.46	2.33	1.46	0.44	1.16	2.77	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	46.85	31.64	10.95	7.30	1.22	0.61	0.61	0.00	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	36.77	10.55	7.53	5.73	0.60	1.51	0.30	0.60	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	64.92	50.67	47.50	36.87	1.58	4.98	1.58	0.90	4.07	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	93.46	51.82	19.17	17.67	2.70	4.19	0.30	0.60	3.29	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	41.33	20.07	15.23	25.27	0.59	3.42	1.30	2.01	2.24	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	59.76	39.27	16.86	14.30	2.77	2.13	1.07	1.07	1.92	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	65.51	34.26	27.04	22.84	1.20	1.80	0.00	0.60	1.80	0.60
Schwann Cells, donor1	11498-119F4	10.91	2.82	0.94	1.50	0.00	0.75	0.00	0.56	0.19	0.00
Schwann Cells, donor2	11578-120F3	3.40	3.40	3.40	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	7.01	2.63	1.97	1.53	0.44	0.00	0.22	0.00	0.66	0.00
Sebocyte, donor1	11220-116B5	46.01	15.89	0.00	2.19	8.76	2.74	3.83	3.83	1.10	1.10
Sebocyte, donor2	11301-117B5	26.65	7.35	1.84	17.46	3.68	0.92	2.30	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	35.04	20.41	2.06	7.83	1.65	2.27	0.82	0.82	0.82	0.00
Sertoli Cells, donor1	11255-116F4	29.82	28.16	14.91	4.97	0.00	1.66	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	45.19	67.78	73.43	70.61	0.00	14.12	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	20.15	8.62	3.08	2.38	0.79	0.53	0.26	0.35	0.26	0.70
Skeletal Muscle Cells, donor2	11358-117H8	12.29	5.78	0.00	2.17	0.00	0.72	0.00	0.72	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	25.92	8.36	3.34	2.51	0.84	0.00	0.00	0.00	2.51	0.84
Skeletal Muscle Cells, donor4	11451-119A2	19.01	9.11	2.04	1.41	0.63	0.16	0.31	0.16	1.26	0.16
Skeletal Muscle Cells, donor5	11455-119A6	17.09	9.22	4.01	2.82	0.30	0.59	0.15	0.30	1.34	0.30
Skeletal Muscle Cells, donor6	11459-119B1	11.85	4.16	2.00	1.85	0.92	0.62	0.00	0.00	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	24.45	8.95	3.53	3.28	0.76	1.13	0.25	0.38	0.50	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	24.40	8.28	4.71	3.28	1.28	0.86	0.14	0.00	0.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.69	10.12	2.48	2.88	0.69	1.19	0.20	0.30	1.09	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	30.25	23.09	6.40	6.91	1.10	1.10	0.42	1.01	0.84	1.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	12.30	5.07	1.45	0.72	0.00	0.72	0.00	0.72	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.23	1.65	0.28	0.69	0.14	0.00	0.00	0.00	0.00	0.28
Skin - palm, donor1	10286-104F7	13.43	2.69	16.12	8.06	2.69	0.00	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	0.29	0.14	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	0.00	1.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	0.70	0.28	0.28	0.28	0.00	0.28	0.00	0.00	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	0.56	0.14	0.00	0.00	0.42	0.00	0.14	0.14	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	0.63	0.42	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	1.27	0.37	0.22	0.37	0.22	0.00	0.15	0.15	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.25	0.62	0.00	0.31	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.22	0.00	0.44	0.67	0.00	0.22	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	2.35	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.54	2.65	0.22	0.00	0.00	0.00	0.44	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.33	3.15	0.39	1.97	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	3.09	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	11.01	4.00	4.00	4.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	1.06	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	25.05	34.58	31.03	11.30	2.44	1.77	0.44	0.44	1.11	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1.41	1.02	0.26	0.13	0.38	0.00	0.00	0.00	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.37	3.91	0.33	2.28	0.65	0.33	0.00	0.00	0.33	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.26	15.95	1.48	3.54	1.18	0.59	0.59	0.30	1.48	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	26.34	28.19	3.56	1.99	1.28	1.28	0.85	0.71	0.85	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	25.38	13.83	1.46	1.14	1.79	0.65	0.16	0.33	0.65	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	8.22	3.35	2.74	4.87	0.00	0.00	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	40.41	17.43	0.76	2.02	0.76	0.76	0.25	0.76	0.76	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.81	1.43	0.95	0.48	0.00	0.00	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.42	12.24	1.92	2.06	1.03	0.59	0.59	0.29	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.80	10.12	3.66	5.17	0.22	1.72	0.00	0.65	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.92	15.43	3.04	3.57	1.15	0.84	0.42	0.52	0.73	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.82	5.26	0.62	0.77	0.77	0.46	0.62	0.31	0.31	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.77	3.29	0.90	0.60	0.60	0.00	1.20	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	46.09	18.44	3.41	3.07	0.68	1.02	0.00	0.34	2.73	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	25.36	9.50	6.05	3.46	0.55	1.02	0.47	0.55	0.47	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	3.12	1.71	1.61	1.61	0.00	0.20	0.10	0.00	0.00	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	2.05	2.96	1.82	1.59	0.00	0.00	0.23	0.23	0.46	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1.81	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	21.46	8.21	9.54	5.30	0.53	1.06	0.00	1.06	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	5.46	4.13	3.06	2.26	0.00	0.13	0.13	0.27	0.40	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	3.88	3.76	2.38	2.63	0.38	0.75	0.38	0.13	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	20.55	16.74	2.79	3.04	0.76	1.01	0.51	1.01	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.02	4.07	0.90	0.60	0.30	0.00	0.60	0.45	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	12.00	0.75	1.50	0.00	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	9.05	2.58	2.58	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	16.74	2.33	0.93	0.47	0.47	0.00	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	2.02	1.51	0.00	1.51	1.01	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.70	4.07	1.88	1.88	0.31	0.63	0.00	0.31	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	14.16	9.73	2.95	2.36	0.88	1.18	0.88	0.29	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	6.83	1.83	0.33	0.50	0.67	0.33	0.25	0.17	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	19.15	7.01	4.20	2.34	0.47	0.47	0.00	0.00	0.47	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	1.44	0.86	0.00	0.00	0.14	0.14	0.14	0.29	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	4.84	1.27	0.76	1.02	0.00	0.00	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.07	0.19	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	5.17	0.70	0.70	0.70	0.28	0.14	0.14	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.61	0.67	0.17	0.25	0.08	0.17	0.00	0.00	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	1.71	0.49	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	4.20	1.55	1.55	3.54	0.44	0.66	0.00	0.22	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	7.90	1.46	0.29	0.88	0.59	0.00	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	33.62	24.30	14.38	7.58	0.97	1.36	0.97	1.17	0.97	2.14
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.46	5.29	6.61	4.50	0.26	0.53	1.06	1.32	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.85	15.62	65.46	47.98	0.37	10.79	0.37	1.49	2.23	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	33.78	36.29	44.92	27.31	0.36	5.03	1.80	4.31	0.72	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1.42	2.84	1.14	0.57	0.28	0.28	0.28	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.67	4.33	8.27	3.94	0.00	1.58	0.39	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	26.92	14.73	31.74	25.65	0.51	2.54	0.76	1.27	1.02	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	14.38	8.39	16.37	5.19	0.40	1.20	0.00	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	18.39	15.05	6.27	0.84	0.84	0.00	0.84	1.67	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	12.38	4.58	3.21	0.92	0.00	0.00	0.00	0.46	1.38	0.92
Synoviocyte, donor1	11291-117A4	59.59	62.28	39.56	28.28	3.87	3.70	2.52	2.19	1.51	2.36
Synoviocyte, donor2	11368-117I9	11.57	4.36	5.70	4.02	1.51	0.84	0.50	0.67	0.34	0.50
Synoviocyte, donor3	11440-118H9	9.83	11.17	11.84	6.48	2.68	1.79	0.45	1.12	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	17.87	5.00	1.07	1.79	0.71	0.36	0.00	0.00	1.07	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	0.00	1.98	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	23.39	7.18	0.93	0.93	0.69	0.69	0.69	0.23	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	2.44	0.29	0.22	0.50	0.14	0.14	0.14	0.07	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	1.55	1.16	0.00	0.39	0.00	0.00	0.39	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.15	0.00	0.00	0.57	0.00	0.00	0.57	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	15.38	8.00	1.48	1.35	0.37	0.62	0.12	0.74	0.25	0.25
Urethra, donor2	10319-105A4	28.77	5.40	14.39	23.38	0.00	0.00	0.00	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.91	0.80	0.00	0.27	0.53	0.00	0.27	0.53	0.27	0.00
Urothelial Cells, donor2	11600-120H7	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.04	0.92	1.15	0.46	0.00	0.23	0.00	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	7.80	1.11	0.00	0.22	0.45	0.00	0.22	0.45	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	12.46	5.34	0.00	0.00	0.00	0.00	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	18.58	4.29	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	13.01	4.11	4.11	5.48	0.00	0.68	0.68	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.05	3.44	2.07	0.69	0.34	0.34	0.00	0.00	0.34	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	12.78	5.23	1.74	1.16	0.00	1.16	0.00	0.00	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	16.66	6.25	0.00	1.04	0.00	1.04	0.00	2.08	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	7.34	1.84	0.00	2.75	0.92	0.00	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	5.48	2.74	3.65	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	89.81	100.66	42.07	23.19	3.82	5.43	0.99	1.36	4.69	1.48
Wilms' tumor cell line:HFWT	10597-108E3	5.28	3.52	0.88	0.00	0.00	0.00	0.88	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	5.31	0.56	1.12	0.56	1.68	0.00	0.56	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	8.27	4.13	8.27	10.33	0.00	0.00	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	31.36	4.84	16.57	8.67	0.25	0.76	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	32.50	2.55	7.43	5.57	0.00	0.23	0.00	0.00	0.93	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	28.57	1.63	9.52	6.53	0.27	0.54	0.27	0.00	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	15.46	1.69	5.06	5.62	0.00	0.56	0.00	0.00	0.84	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	15.65	3.81	0.00	1.27	0.00	0.42	0.00	0.00	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	37.84	16.88	16.88	15.79	0.00	1.91	0.00	1.36	1.09	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	2.20	0.88	0.00	0.88	0.00	0.44	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	10.21	0.82	2.45	4.08	0.00	0.00	0.00	0.41	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.18	0.00	0.18	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	3.49	0.70	0.93	0.70	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.63	0.29	1.46	1.17	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.01	2.32	0.46	1.39	0.00	0.00	0.00	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	28.38	6.99	8.23	6.58	0.00	0.82	0.41	0.00	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.14	0.92	0.92	0.31	0.31	0.00	0.00	0.00	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	9.81	2.99	0.00	1.28	0.43	0.00	0.00	0.00	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	10.92	2.12	0.30	0.30	0.30	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	13.96	1.20	1.20	1.68	0.24	0.24	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.37	0.67	4.45	3.56	0.00	0.67	0.00	0.00	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	19.78	5.65	3.53	2.35	4.24	0.00	2.35	5.65	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	26.84	9.00	1.71	4.65	1.55	1.09	0.62	0.93	0.31	1.09
adipose, donor1	10184-103D4	26.97	1.17	42.81	30.49	0.00	0.59	0.00	0.00	4.10	0.59
adipose, donor2	10185-103D5	30.01	2.84	6.08	4.87	1.22	0.00	0.41	0.00	0.41	0.81
adipose, donor3	10186-103D6	16.07	3.81	13.07	8.44	0.82	0.82	0.27	0.00	1.36	2.18
adipose, donor4	10187-103D7	16.47	5.20	15.60	5.20	0.00	0.87	0.00	0.00	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	2.53	0.16	0.63	0.16	0.00	0.32	0.00	0.00	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	3.64	0.00	0.00	0.00	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	7.15	1.43	2.50	1.43	0.00	1.07	0.00	0.00	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	0.23	0.00	0.00	0.00	0.00	0.23	0.23	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	0.68	0.00	0.00	0.00	0.34	0.00	0.00	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	45.06	7.11	20.16	5.93	0.00	1.19	1.19	1.19	3.56	0.00
amygdala, adult, donor10252	10151-102I7	32.04	9.73	15.00	20.68	0.00	1.42	0.00	0.00	1.62	1.01
amygdala, newborn, donor10223	10360-105E9	24.53	4.52	11.30	3.55	0.00	0.97	0.65	0.00	1.29	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	1.02	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	60.46	29.40	22.38	12.69	3.34	0.67	0.00	1.34	2.34	0.67
aorta, adult, pool1	10052-101G7	14.51	4.90	6.67	4.51	0.20	1.77	0.98	0.59	0.39	0.78
appendix, adult	10189-103D9	15.14	6.21	1.94	1.55	0.78	0.00	0.78	3.49	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1.72	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.34	0.00
artery, adult	10190-103E1	9.51	2.72	4.08	2.72	1.36	2.72	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	138.78	69.25	19.99	23.18	3.48	2.75	0.58	1.59	3.62	7.24
b cell line:RPMI1788	10427-106D4	0.00	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.87	8.32	3.61	4.99	1.94	0.83	1.11	0.55	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	0.79	0.10	0.20	0.10	0.10	0.00	0.10	0.10	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	11.88	3.68	2.85	1.84	1.00	0.33	0.84	0.33	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1.68	0.00	0.56	0.56	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	17.49	4.45	2.06	2.17	0.33	1.09	0.33	0.11	0.22	0.11
blood, adult, pool1	10053-101G8	8.86	6.64	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	9.42	11.13	1.71	1.71	3.43	0.00	0.00	0.86	1.71	0.86
bone marrow, adult	10192-103E3	29.69	35.09	81.65	71.53	0.00	9.45	1.35	2.02	0.67	2.02
brain, adult, donor1	10084-102B3	16.40	6.15	6.15	1.03	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	13.25	3.56	1.78	2.45	0.11	0.22	0.56	0.33	0.67	0.33
brain, fetal, pool1	10085-102B4	72.13	42.74	13.36	16.03	0.00	0.00	2.67	2.67	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	29.07	17.18	7.60	5.62	2.31	0.99	0.33	0.66	0.33	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	43.31	15.48	3.00	3.62	0.62	0.50	0.75	0.50	0.12	0.62
breast, adult, donor1	10080-102A8	21.47	5.68	4.42	6.31	0.00	0.00	1.26	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.24	2.03	2.29	1.65	1.27	0.51	1.78	1.40	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	6.18	0.62	2.47	1.24	0.31	0.00	0.00	0.62	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	55.01	12.69	9.40	4.70	0.47	0.47	0.00	0.00	1.88	1.41
carcinoid cell line:NCI-H727	10735-110B6	51.41	19.47	3.17	5.03	2.19	1.20	0.98	1.20	1.20	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	4.75	0.32	2.22	1.58	0.00	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	20.23	9.32	11.98	6.65	0.27	1.06	0.00	0.00	1.06	0.53
caudate nucleus - adult, donor10196	10177-103C6	5.76	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	6.86	1.67	2.01	0.84	0.00	0.50	0.17	0.17	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	5.35	0.76	0.76	0.76	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	6.59	2.20	2.20	1.83	0.37	0.37	0.00	0.37	0.00	1.10
cerebellum - adult, donor10196	10173-103C2	46.61	8.74	5.83	0.00	2.91	0.00	2.91	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	74.09	24.13	15.59	20.92	0.64	4.48	0.85	0.85	3.42	1.71
cerebellum, adult, pool1	10083-102B2	25.18	12.76	15.52	5.86	1.38	0.34	0.00	0.34	1.38	1.03
cerebellum, newborn, donor10223	10357-105E6	14.95	4.98	10.79	5.81	0.00	0.00	0.00	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	21.43	9.08	5.04	5.29	0.00	0.25	1.01	0.50	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	5.85	3.65	15.35	5.12	0.73	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	7.91	2.01	1.15	1.01	0.58	0.58	0.14	0.00	0.14	0.14
cervical cancer cell line:ME-180	10553-107I4	9.28	1.16	2.32	1.33	1.33	1.16	2.98	1.82	0.33	0.00
cervix, adult, pool1	10013-101C4	18.37	4.20	2.52	2.10	0.73	0.31	0.52	0.94	0.10	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	32.61	21.88	8.64	5.85	1.95	1.81	0.98	0.56	1.25	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	14.37	0.00	1.31	0.00	1.31	0.00	2.61	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	0.86	0.37	0.49	0.12	0.00	0.00	0.00	0.12	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	0.24	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	1.14	0.85	0.28	0.00	0.00	0.00	0.57	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	19.49	8.75	2.49	2.09	0.80	0.40	0.60	0.50	0.20	0.40
chorionic membrane cells, donor3	12240-129G8	1.10	0.00	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2.96	0.21	0.63	0.21	0.00	0.00	0.21	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.97	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.59	0.00	0.29	0.29	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	5.21	0.78	0.78	0.52	0.00	0.00	0.00	0.00	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	0.23	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	0.17	0.00	0.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	3.11	0.18	0.18	0.18	0.00	0.00	0.18	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	20.23	7.14	11.90	8.33	0.00	0.00	8.33	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	17.39	5.76	1.53	1.06	1.06	0.24	4.00	1.53	0.00	0.47
colon, fetal, donor1	10070-101I7	11.12	6.18	4.33	2.47	0.62	0.00	1.24	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	9.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	13.75
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	14.45	0.42	2.12	4.67	0.00	0.00	0.00	0.00	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.49	3.02	0.91	1.51	0.45	0.30	0.00	0.00	0.91	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	15.51	2.82	2.82	2.68	0.42	0.00	0.14	0.14	0.56	0.42
corpus callosum, adult, pool1	10042-101F6	13.16	6.52	1.33	1.88	0.00	0.33	0.11	0.00	0.11	0.66
cruciate ligament, donor2	10295-104G7	12.16	3.24	10.54	6.48	0.00	0.00	1.62	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	14.45	8.03	8.03	2.41	0.00	0.80	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	3.36	0.48	1.68	0.72	0.00	0.00	0.00	0.48	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	3.90	0.23	3.21	0.92	0.00	0.00	0.00	0.00	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	20.77	3.85	1.80	0.77	2.82	0.51	1.54	1.03	0.26	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	2.41	0.96	1.20	1.20	0.00	0.00	0.24	0.00	0.24	0.00
ductus deferens, adult	10196-103E7	15.45	11.96	5.48	5.98	1.00	0.50	0.50	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	8.64	17.28	7.20	2.88	0.00	1.44	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.07	7.36	3.68	8.09	0.00	0.00	2.21	0.00	2.21	0.00
dura mater, adult, donor1	10041-101F5	39.31	21.97	4.62	6.85	4.21	1.65	1.40	1.57	0.66	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	5.55	1.11	0.00	0.89	0.00	0.00	0.00	0.22	0.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	8.60	0.72	1.29	1.43	0.43	0.29	0.00	0.14	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	3.70	0.00	0.00	0.00	0.00	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	3.33	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	3.09	0.00	0.31	0.31	0.31	0.00	0.00	0.00	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	2.63	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	10.51	1.99	3.99	2.36	0.00	0.36	0.18	0.18	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.76	8.68	8.04	7.88	1.13	1.13	1.29	0.96	0.64	1.13
epidermoid carcinoma cell line:A431	10426-106D3	17.23	5.45	1.67	2.89	4.34	0.78	6.11	4.34	0.22	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	4.18	1.32	0.33	0.44	0.44	0.33	0.22	0.33	0.22	0.00
epididymis, adult	10197-103E8	11.09	5.02	2.30	2.30	0.42	0.42	1.05	0.00	0.21	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	0.53	0.00	0.18	0.35	0.00	0.00	0.00	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1.18	0.39	0.39	0.39	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.26	0.00	0.00	0.00	0.00	0.00	0.13	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.11	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	14.33	5.95	1.06	1.81	0.85	0.21	1.17	0.32	0.11	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1.63	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	14.49	9.66	48.29	26.56	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	2.10	12.63	14.73	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	13.39	1.49	8.93	13.39	0.00	0.00	1.49	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	10.32	6.88	17.20	3.44	0.00	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	2.91	1.46	4.37	1.46	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	16.78	6.86	5.34	5.34	0.51	0.51	1.27	0.51	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	0.26	0.13	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	0.24	0.24	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	23.64	6.19	1.88	1.97	0.19	0.94	0.19	0.38	0.84	0.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.21	3.00	17.11	11.11	1.20	0.30	0.60	1.20	0.60	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	0.27	0.09	0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.09
gall bladder, adult	10198-103E9	22.21	8.45	4.10	5.55	2.17	0.24	6.04	3.38	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	17.18	2.15	1.07	0.54	0.00	0.00	0.00	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	8.22	0.37	1.12	0.37	0.37	0.00	0.37	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	7.39	4.65	3.80	3.38	1.06	0.63	0.42	0.21	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	17.99	4.84	4.26	2.90	1.55	0.39	1.16	0.77	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	4.26	0.98	0.66	0.82	0.16	0.00	0.16	0.33	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	1.83	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	17.59	9.60	6.63	3.66	0.23	0.91	0.46	0.46	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	2.24	0.14	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	7.48	3.49	1.75	2.99	1.00	0.00	1.75	1.75	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	12.56	4.22	2.22	2.74	0.63	0.11	0.21	0.00	0.21	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	11.38	4.49	5.20	1.97	0.28	0.14	0.28	0.28	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	33.99	17.00	8.72	7.73	1.77	0.99	0.44	0.66	0.33	0.44
glioma cell line:GI-1	10413-106B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	3.64	0.00	0.00	2.19	0.00	0.00	0.00	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	10.98	4.39	3.42	3.91	0.49	0.49	0.00	0.00	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	2.74	0.00	8.22	0.00	1.37	0.00	0.00	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	4.26	0.53	1.07	0.53	0.00	0.00	0.00	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	9.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	46.08	39.68	13.12	14.72	1.28	2.56	0.00	0.64	1.60	0.64
hIPS +CCl2, biol_rep1	14383-156B9	16.53	6.89	5.97	2.30	0.46	0.00	0.00	0.00	2.75	4.13
hIPS +CCl2, biol_rep2	14384-156C1	15.09	6.40	5.03	0.91	0.00	0.00	0.00	0.46	2.29	3.20
hIPS +CCl2, biol_rep3	14385-156C2	20.61	7.09	5.15	1.93	0.00	0.00	0.00	0.00	1.29	1.93
hIPS, biol_rep1	14380-156B6	4.31	1.44	10.06	2.87	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	11.66	4.80	5.49	0.69	0.00	0.00	0.00	0.00	0.69	2.74
hIPS, biol_rep3	14382-156B8	12.14	2.21	2.21	0.00	0.00	0.00	0.00	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	0.57	0.00	0.29	0.29	0.29	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	19.73	10.46	7.47	5.68	0.60	0.30	0.60	0.60	0.00	0.90
heart - pulmonic valve, adult	10206-103F8	16.73	6.54	12.81	6.01	1.05	0.78	0.00	0.26	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	14.99	7.49	9.16	3.33	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	23.67	6.12	8.77	6.12	2.04	1.84	1.43	3.06	0.61	0.41
heart, adult, diseased, donor1	10051-101G6	22.57	5.54	12.77	8.94	0.85	0.85	0.85	0.00	0.43	0.85
heart, adult, pool1	10016-101C7	19.32	8.74	0.46	1.15	0.00	0.46	0.00	0.23	0.00	0.92
heart, fetal, pool1	10046-101G1	50.62	17.56	3.49	4.52	1.54	0.82	0.21	0.62	0.82	1.13
hepatic mesenchymal tumor cell line:LI90	10778-110G4	80.22	91.63	33.63	20.36	2.47	2.47	1.23	1.85	0.93	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	6.34	2.11	0.67	1.11	0.44	0.33	0.33	0.11	0.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.70	0.30	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	10.41	4.73	10.41	3.79	0.00	0.00	0.00	0.00	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	13.88	6.33	8.16	5.71	0.00	0.61	0.20	0.20	0.82	0.20
hippocampus, adult, donor10258	10374-105G5	7.97	2.49	1.99	1.00	0.00	0.50	0.00	0.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	25.03	9.87	3.88	2.82	0.00	0.00	0.00	0.00	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	5.49	1.22	2.44	1.83	0.00	0.61	0.00	0.00	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	9.43	2.55	3.53	0.98	0.39	0.79	0.20	0.00	1.77	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.92	1.78	2.79	0.76	0.25	0.25	0.00	0.25	1.52	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	84.02	25.94	15.79	23.68	1.69	1.69	0.00	0.56	8.46	5.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	90.37	22.46	38.22	42.60	1.55	7.23	0.52	0.52	7.49	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	93.38	28.09	14.43	18.22	1.90	2.66	0.38	0.00	6.07	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	17.81	2.04	2.63	1.46	0.29	0.29	0.29	0.29	0.58	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.13	3.88	5.39	5.39	0.22	0.43	0.22	0.43	1.29	2.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	18.77	2.92	2.09	2.09	0.83	0.42	0.42	0.00	0.42	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.08	2.13	1.18	1.18	0.47	1.18	0.00	1.18	0.95	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	15.43	3.86	4.98	3.38	0.80	0.80	0.48	0.32	0.48	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	2.02	0.00	0.67	0.67	0.00	0.00	0.67	1.35	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.35	1.72	2.82	1.10	0.16	0.63	0.00	0.16	0.94	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	1.97	4.42	2.95	0.00	0.00	0.00	0.00	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.87	0.00	3.49	3.49	0.00	1.75	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	77.89	18.71	18.71	15.27	2.67	1.72	0.19	0.19	3.05	2.48
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	52.76	13.52	12.21	10.03	1.31	2.62	0.44	0.00	2.18	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	40.48	4.00	14.49	11.49	1.50	0.00	0.00	0.00	4.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	22.42	1.88	8.10	5.09	0.94	0.57	0.57	0.38	1.88	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	17.28	3.18	4.09	2.27	0.00	0.45	0.00	0.00	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.99	4.07	4.07	2.82	0.31	0.00	0.94	0.00	2.82	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	18.78	4.74	8.33	5.39	1.14	0.49	0.16	0.33	1.31	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	15.39	2.03	6.97	4.64	0.29	1.16	0.00	0.29	1.16	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	19.73	5.38	8.07	2.99	0.30	0.90	0.90	0.30	1.49	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.43	2.77	10.90	6.28	0.00	1.48	0.00	0.00	1.85	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.11	3.71	7.99	3.71	0.29	0.86	0.00	0.29	2.28	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	21.64	5.31	6.12	7.35	0.00	0.00	0.00	0.00	0.41	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	45.77	12.67	11.62	13.73	1.06	4.58	0.35	0.00	3.52	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	51.95	14.89	16.79	10.14	0.63	0.95	0.00	0.00	2.85	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	58.10	17.25	12.41	8.17	0.61	2.42	0.00	0.61	4.84	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	20.17	4.65	6.21	3.62	0.00	0.00	0.52	0.00	1.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.93	1.33	3.32	3.98	0.00	0.00	1.33	0.66	2.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	17.44	3.85	3.59	1.80	1.28	0.26	0.00	0.26	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	18.92	5.62	3.32	3.58	0.26	0.77	0.26	0.00	1.28	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.84	0.76	5.30	3.79	0.00	0.00	0.00	0.00	0.76	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.15	5.38	3.36	3.36	1.01	1.01	0.34	0.67	1.34	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.91	5.80	9.90	3.86	0.24	0.72	0.00	0.24	1.93	4.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	22.73	2.67	6.68	4.90	0.45	0.00	0.45	0.45	0.00	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	20.98	4.39	5.37	2.93	0.98	0.98	0.00	0.00	2.44	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	67.54	17.73	16.20	14.67	1.22	4.58	0.61	0.00	4.89	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	26.03	0.00	107.36	117.12	0.00	6.51	0.00	0.00	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	58.25	9.93	23.50	20.85	0.66	1.65	0.00	0.33	4.63	3.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	20.25	3.83	3.28	3.83	0.55	1.09	0.00	0.00	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.18	2.17	1.81	3.98	0.00	0.72	0.00	0.36	2.53	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	18.86	2.85	4.27	1.42	0.71	0.36	0.00	0.36	1.42	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	3.58	3.58	2.39	0.00	0.00	0.00	0.00	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	21.26	3.11	2.57	4.06	0.27	0.54	0.41	0.41	1.76	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.28	2.96	3.77	3.23	0.81	0.27	0.00	0.00	1.35	2.16
immature langerhans cells, donor1	11904-125F5	0.73	0.24	0.24	0.24	0.00	0.00	0.00	0.00	0.00	0.24
immature langerhans cells, donor2	11905-125F6	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	44.95	8.42	3.50	2.93	0.38	1.04	0.28	0.38	1.80	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	6.50	0.65	1.63	0.33	1.95	0.00	1.63	2.28	0.00	0.33
kidney, adult, pool1	10017-101C8	8.01	3.80	0.90	1.90	0.60	0.20	0.70	0.60	0.20	0.30
kidney, fetal, pool1	10045-101F9	39.75	13.02	2.26	2.48	0.78	1.34	0.35	0.35	0.50	0.78
large cell lung carcinoma cell line:IA-LM	10509-107D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	4.59	0.37	0.18	0.18	0.37	0.00	0.18	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	26.70	6.54	5.99	7.63	1.09	1.09	0.00	0.00	0.54	0.54
left ventricle, adult, donor1	10078-102A6	15.68	4.55	2.53	2.02	0.00	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.27	0.00	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	6.47	3.23	1.44	2.16	0.00	1.08	0.00	0.00	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	10.33	5.43	2.72	2.72	1.09	0.54	1.09	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	12.63	3.40	2.19	4.61	1.46	0.97	0.49	0.49	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	57.14	6.35	12.70	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	3.14	3.14	1.05	1.05	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.71	0.24	0.12	0.12	0.00	0.12	0.00	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	5.62	2.03	2.19	0.78	0.62	0.00	0.47	0.31	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	27.05	7.31	3.29	0.97	1.46	0.37	0.49	0.97	0.37	0.37
liver, adult, pool1	10018-101C9	5.83	3.57	0.81	0.49	0.32	0.65	0.16	0.32	0.00	0.16
liver, fetal, pool1	10086-102B5	0.94	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	6.56	1.02	4.08	2.62	0.00	0.00	0.00	0.15	0.15	0.58
locus coeruleus, adult, donor10252	10165-103B3	11.44	6.09	7.20	4.06	0.37	0.55	0.18	0.00	0.18	0.55
locus coeruleus, adult, donor10258	10375-105G6	9.87	3.39	4.80	2.54	0.00	0.85	0.00	0.00	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	6.31	1.26	9.67	8.83	0.42	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	8.44	2.35	0.55	0.83	0.28	0.14	0.14	0.42	0.14	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	24.65	4.48	1.32	1.85	1.19	0.66	0.40	0.13	0.00	0.13
lung, adult, pool1	10019-101D1	23.63	6.62	3.31	3.54	1.30	0.24	0.59	0.71	0.12	0.24
lung, fetal, donor1	10068-101I5	21.12	5.99	5.14	6.28	1.14	0.00	2.28	2.00	0.57	2.00
lung, right lower lobe, adult, donor1	10075-102A3	21.99	6.87	19.25	8.25	0.92	0.92	1.37	1.37	0.00	0.46
lymph node, adult, donor1	10077-102A5	12.31	3.31	10.89	3.31	0.95	0.47	0.00	0.00	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	7.55	0.75	0.60	1.51	0.00	0.00	0.00	0.15	0.15	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	3.40	0.00	0.85	0.85	0.85	0.00	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	4.88	1.33	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.89
mature adipocyte, donor2	12232-129F9	7.89	2.49	0.21	0.21	0.42	0.00	0.00	0.00	0.42	0.83
mature adipocyte, donor3	12233-129G1	6.64	2.37	0.24	0.95	0.24	0.00	0.00	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	4.74	1.05	0.26	0.26	0.00	0.00	0.26	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	5.48	0.95	0.00	0.24	0.24	0.00	0.71	0.24	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	6.77	1.13	5.64	2.26	0.00	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	15.45	4.41	4.41	2.94	0.00	0.55	0.00	0.00	0.55	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	5.72	1.59	3.81	0.64	0.00	0.00	0.32	0.32	0.32	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	13.65	1.71	19.62	13.65	0.00	0.85	0.43	0.85	2.13	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	14.34	2.87	5.57	8.78	0.00	2.53	0.00	0.17	1.35	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	14.43	3.82	11.88	9.13	0.00	0.42	0.00	0.21	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	0.00	5.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	215.30	86.12	0.00	0.00	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	35.18	5.74	9.33	5.74	0.72	1.08	0.72	0.36	2.51	1.79
medulla oblongata - adult, donor10196	10174-103C3	3.24	0.00	6.49	1.95	0.00	0.00	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	19.35	13.31	6.35	7.43	0.15	1.86	0.46	0.62	0.77	0.46
medulla oblongata, adult, pool1	10038-101F2	18.69	5.31	1.80	2.69	0.57	0.73	0.41	0.65	0.82	1.55
medulla oblongata, newborn, donor10223	10361-105F1	3.82	1.04	1.39	0.69	0.35	0.00	0.35	0.35	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	12.84	5.09	5.54	5.31	0.00	0.22	0.00	0.00	0.44	0.44
medulloblastoma cell line:ONS-76	10759-110E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	5.97	0.27	1.90	1.36	0.54	0.00	0.27	0.00	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	5.43	0.54	0.54	0.36	0.72	0.18	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	10.57	3.52	3.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	14.00	4.15	1.81	1.56	0.00	0.00	0.00	0.00	1.04	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.43	7.52	3.22	3.68	0.46	1.07	0.00	0.00	0.61	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.18	8.73	3.27	4.73	0.55	0.73	0.18	0.18	0.18	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.84	4.56	4.14	3.31	0.41	0.00	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.07	1.97	0.56	0.98	0.00	0.28	0.00	0.14	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.41	12.52	4.24	3.66	0.19	0.58	0.39	0.19	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	5.55	1.39	0.69	0.00	0.69	0.69	2.78	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.81	1.54	1.03	0.34	0.51	0.00	0.34	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.36	9.66	3.80	4.37	0.58	1.15	0.46	0.35	0.69	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.31	3.18	2.25	0.53	0.40	0.00	0.00	0.13	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4.05	0.81	0.81	0.81	0.41	0.41	0.14	0.27	0.68	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	10.81	4.69	2.85	1.99	0.28	0.85	0.14	0.57	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	4.28	1.98	0.99	1.98	0.33	0.00	0.00	0.33	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	14.25	4.01	2.49	2.35	0.55	0.55	0.14	0.55	1.11	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.85	6.28	3.84	4.54	0.70	0.70	0.00	0.00	1.75	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.23	3.47	1.02	1.84	0.00	0.41	0.41	0.41	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	13.66	7.19	3.95	4.31	1.80	0.00	0.00	0.36	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.59	6.52	3.41	3.10	0.93	0.72	0.21	0.31	0.52	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.50	7.30	7.07	5.93	1.60	0.91	0.46	0.91	0.91	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.23	4.20	4.62	4.20	0.00	0.42	0.42	1.68	2.10	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.98	11.21	6.43	4.93	0.30	0.60	0.30	0.30	0.45	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.42	3.94	1.58	1.49	0.18	0.44	0.09	0.26	0.44	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	30.56	9.20	3.68	2.58	0.37	0.74	0.00	0.00	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.46	13.16	7.44	9.73	2.00	1.14	0.57	0.29	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	6.32	0.84	2.11	2.53	0.42	0.84	0.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	6.85	2.74	1.37	0.46	0.00	0.46	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.30	5.88	2.56	3.58	1.02	0.51	0.51	0.77	0.00	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.30	8.11	2.09	1.57	0.79	0.00	0.79	0.52	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.25	9.55	5.24	2.16	0.92	0.31	0.62	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.94	8.00	3.29	3.29	0.94	0.94	0.47	0.47	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.51	5.75	2.71	2.71	1.02	0.34	0.34	0.00	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.82	7.86	5.89	1.57	0.00	0.79	0.39	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.41	7.41	2.32	1.39	1.39	0.46	0.00	0.93	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.40	8.36	5.48	3.75	1.15	0.29	0.29	1.15	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.72	9.82	1.34	1.34	1.12	0.22	0.67	0.67	0.89	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.46	8.41	2.88	3.12	0.72	0.24	0.96	0.96	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.20	8.80	1.47	2.93	0.73	0.73	0.00	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.41	4.36	2.69	2.69	0.67	1.01	0.00	1.68	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	6.96	3.28	2.05	0.00	0.41	1.23	0.82	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.32	5.58	4.30	1.29	0.43	0.86	0.43	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	10.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	5.16	5.16	5.16	0.00	0.00	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.47	5.52	2.27	2.27	0.65	0.32	0.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	2.91	0.00	1.45	1.45	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.13	5.86	1.60	3.20	0.53	1.60	0.53	0.53	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	4.91	4.91	3.27	0.00	0.82	0.00	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.89	6.61	3.89	3.50	0.39	0.39	0.39	0.39	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	4.20	0.00	10.49	0.00	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	1.99	2.98	1.99	0.00	0.00	0.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	4.77	9.53	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	6.52	6.52	2.37	1.78	1.19	0.00	0.59	1.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	3.66	1.22	1.22	0.00	0.00	0.00	0.00	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	3.17	3.80	1.27	1.90	0.00	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.45	1.72	1.03	2.07	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	0.00	4.30	4.30	0.00	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.48	6.52	2.85	1.63	0.81	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	2.38	0.79	0.79	0.00	0.00	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	2.36	2.36	1.77	0.00	0.00	0.59	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	3.74	1.87	1.25	0.00	0.00	0.00	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	4.01	4.01	1.34	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	3.55	2.37	3.55	0.00	1.18	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	5.14	2.57	2.57	0.00	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.83	4.82	4.82	2.75	0.00	0.00	0.00	1.38	2.07	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	15.83	3.96	0.49	0.99	0.00	0.00	0.99	0.00	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	2.24	2.24	3.36	2.24	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	5.72	5.72	1.91	0.00	1.27	0.64	0.00	0.64	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.07	3.22	1.21	1.21	0.40	0.00	0.00	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	2.18	2.18	0.00	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	5.07	1.27	1.27	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.07	5.46	0.00	1.21	0.00	0.00	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	13.56	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	3.29	0.82	1.65	1.65	0.82	0.00	0.00	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.82	16.27	1.98	1.79	0.79	0.40	0.00	0.79	0.20	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	21.42	15.90	5.19	5.52	2.27	0.32	0.32	1.30	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	31.58	11.20	9.17	3.06	3.06	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.93	1.55	0.00	0.00	0.00	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	10.16	1.18	1.18	2.13	0.47	0.24	0.00	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	22.01	12.28	4.40	4.17	1.62	0.46	0.93	0.93	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	8.55	0.00	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.24	1.54	8.12	5.03	0.41	0.31	0.00	0.10	0.31	0.00
mesothelioma cell line:Mero-25	10850-111F4	3.40	0.91	0.91	1.13	0.68	0.00	0.00	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	20.54	7.82	11.25	8.80	2.44	0.73	0.73	1.71	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	2.44	0.44	1.11	0.66	0.00	0.22	0.00	0.00	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	2.37	1.31	3.42	2.63	0.26	0.00	0.00	0.26	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.17	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	4.30	2.27	1.52	1.77	0.76	0.51	0.25	0.51	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	9.52	4.97	3.73	2.48	0.83	0.41	0.41	0.62	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	13.75	4.47	4.97	2.65	0.83	0.99	0.17	0.66	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	7.78	2.90	3.26	2.71	0.90	0.00	0.54	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	4.44	0.85	2.39	0.68	0.34	0.34	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	5.34	1.53	1.02	2.04	0.51	0.25	0.00	0.00	0.00	0.25
mesothelioma cell line:No36	10857-111G2	3.26	0.65	0.98	0.65	0.65	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	6.23	0.27	2.98	1.08	0.81	0.00	0.00	0.00	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	4.41	0.77	1.15	1.73	0.00	0.19	0.00	0.19	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	7.82	2.08	1.34	1.95	0.00	0.24	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	6.10	1.26	1.26	1.79	0.18	0.36	0.18	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.02	5.55	13.06	8.49	0.98	1.31	0.33	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	18.43	8.98	2.76	2.07	2.53	0.00	0.23	1.38	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.19	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	14.04	1.48	1.66	2.40	0.00	0.37	0.00	0.00	0.18	0.18
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	12.68	3.55	1.52	2.03	0.00	0.00	0.00	2.03	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	2.56	0.78	0.11	0.22	0.67	0.11	0.56	0.56	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	1.76	0.37	0.15	0.15	0.59	0.15	0.51	0.37	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	2.76	0.55	0.00	0.55	0.00	0.55	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	172.55	62.81	17.71	20.25	0.23	3.22	0.23	0.00	10.12	5.98
neuroblastoma cell line:NB-1	10539-107G8	75.77	27.31	11.60	7.11	0.75	1.87	0.37	0.19	3.55	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	2.11	0.21	0.63	0.21	0.00	0.00	0.00	0.00	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	25.16	3.35	2.98	3.54	0.00	0.37	0.00	0.00	0.75	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	8.07	1.42	3.32	1.66	0.00	0.47	0.00	0.00	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1.90	0.00	0.16	0.16	0.00	0.00	0.00	0.00	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	40.05	2.54	3.81	1.91	0.00	0.00	0.00	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	51.64	54.83	9.58	6.92	1.33	1.06	0.80	0.80	1.33	1.33
neutrophil PMN, donor1	12133-128D9	327.25	44.62	0.00	0.00	29.75	0.00	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	39.84	26.56	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	12.01	0.68	0.51	1.35	0.00	0.00	0.00	0.00	0.51	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	6.40	5.60	0.80	0.00	0.00	0.00	0.00	0.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.48	13.47	10.58	5.13	1.92	1.60	0.00	0.64	1.28	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	49.66	99.06	35.74	38.89	4.47	6.83	1.05	2.63	2.10	0.79
nucleus accumbens, adult, pool1	10037-101F1	16.03	4.50	1.41	1.78	0.09	0.66	0.28	0.19	1.22	0.56
occipital cortex - adult, donor10196	10172-103C1	8.24	2.06	4.12	4.12	0.00	2.06	0.00	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	16.64	3.76	8.86	7.25	0.27	1.07	0.00	0.00	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	26.20	5.10	2.18	1.46	0.36	1.46	0.36	0.36	3.28	1.09
occipital lobe, adult, donor1	10076-102A4	16.53	4.46	6.30	3.15	0.00	0.26	0.00	0.52	1.05	1.05
occipital lobe, fetal, donor1	10073-102A1	69.51	19.74	44.63	29.18	1.72	3.43	0.86	0.00	2.57	2.15
occipital pole, adult, pool1	10036-101E9	23.57	4.89	1.02	1.89	0.39	0.47	0.55	0.08	0.55	0.79
olfactory region, adult	10195-103E6	8.02	4.97	8.60	6.11	0.38	0.00	0.19	0.19	0.76	0.38
optic nerve, donor1	10277-104E7	16.01	2.00	4.00	6.00	4.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	0.23	0.23	0.00	0.00	0.11	0.00	0.11	0.11	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.03	0.41	0.96	0.69	0.27	0.00	0.41	0.41	0.41	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	0.85	0.17	0.34	0.51	0.51	0.00	0.34	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	2.89	0.81	0.81	0.81	0.23	0.00	0.00	0.12	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	14.11	7.06	4.12	2.35	0.88	0.29	0.29	0.29	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	6.54	0.00	0.93	0.00	0.93	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	75.07	63.83	21.21	17.60	1.91	2.76	0.64	0.64	2.54	1.48
ovary, adult, pool1	10020-101D2	21.40	4.63	2.45	2.45	0.70	0.52	0.52	0.79	0.52	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	0.37	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	10.35	2.82	0.94	1.88	0.00	0.94	0.94	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	1.36	0.34	0.85	0.51	0.17	0.00	0.17	0.00	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	11.76	1.99	0.66	1.32	0.99	0.00	0.50	0.66	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	17.11	4.03	2.11	1.56	0.00	0.37	0.46	0.09	0.55	0.73
parietal cortex, adult, donor10258	10373-105G4	2.20	0.73	0.73	2.20	0.00	0.73	0.00	0.00	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	0.94	2.82	1.88	0.00	0.94	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	10.83	3.42	6.84	5.13	0.29	0.29	0.00	0.00	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	13.39	4.76	1.32	1.94	0.09	0.53	0.18	0.00	0.26	0.35
parietal lobe, fetal, donor1	10072-101I9	66.92	18.43	80.50	41.70	0.97	2.91	0.97	0.97	5.82	0.00
parietal lobe, newborn, donor10223	10356-105E5	26.54	5.98	12.34	7.48	0.00	0.37	0.37	0.00	2.99	1.50
parotid gland, adult	10199-103F1	19.73	6.17	1.23	0.62	0.62	0.62	0.00	0.62	0.00	0.62
penis, adult	10200-103F2	16.11	3.76	5.37	5.37	0.54	2.15	1.61	1.61	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.23	0.74	0.74	0.56	0.00	0.00	0.00	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	22.87	6.99	7.43	4.23	2.62	0.58	1.60	2.04	0.44	0.29
pineal gland - adult, donor10196	10179-103C8	3.23	1.94	1.94	1.94	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	4.74	1.18	7.70	1.78	0.59	0.59	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	2.51	0.63	1.88	0.63	0.00	0.63	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	10.12	4.05	9.11	1.01	0.00	1.01	1.01	3.04	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	20.85	7.82	8.86	2.61	0.52	1.04	0.00	0.52	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	3.40	1.70	3.40	5.96	0.00	0.85	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	13.33	6.02	1.18	2.58	0.22	0.86	0.22	0.22	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	8.21	1.32	1.32	0.93	0.00	0.13	0.13	0.00	0.40	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.92	11.21	2.65	3.42	0.78	0.31	0.47	0.47	0.16	0.31
pons, adult, pool1	10033-101E6	11.02	3.18	1.38	0.95	0.43	0.43	0.17	0.26	0.52	0.52
postcentral gyrus, adult, pool1	10032-101E5	18.05	5.23	1.57	1.13	0.70	0.70	0.26	0.00	0.87	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.04	4.08	5.54	5.68	0.87	0.58	0.29	0.29	0.29	0.44
prostate cancer cell line:PC-3	10439-106E7	17.61	4.90	8.53	4.90	1.27	0.54	0.73	0.36	0.36	0.00
prostate, adult, pool1	10022-101D4	18.77	5.08	1.09	1.54	0.82	0.63	0.73	0.63	0.18	0.45
putamen, adult, donor10196	10176-103C5	5.90	1.65	1.42	2.60	0.00	0.24	0.00	0.00	0.24	0.24
putamen, adult, donor10252	10152-102I8	5.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	3.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	2.17	0.72	0.97	0.24	0.00	0.00	0.00	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	5.25	2.25	6.00	0.00	0.00	0.75	0.00	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	30.60	5.56	6.95	2.78	0.00	0.00	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	0.21	0.00	0.00	0.00	0.00	0.00	0.21	0.00	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	0.00	0.00	0.83	1.24	0.00	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	24.65	9.84	2.68	2.78	1.19	1.19	0.50	0.70	0.30	0.50
retinoblastoma cell line:Y79	10475-106I7	76.12	18.71	21.56	19.49	0.52	1.82	0.52	0.00	3.90	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.59	1.97	1.41	1.97	0.28	0.28	0.00	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	48.50	26.52	9.09	2.27	3.03	0.76	0.76	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	20.88	19.75	10.68	7.45	2.91	1.29	6.47	5.18	0.65	0.32
salivary acinar cells, donor2	11772-123I8	47.78	43.92	16.94	18.31	3.86	3.17	7.02	6.88	1.51	1.10
salivary acinar cells, donor3	11773-123I9	38.40	37.07	11.92	16.55	3.31	2.65	1.99	2.65	1.32	0.00
salivary gland, adult, pool1	10093-102C3	8.01	4.58	0.00	1.14	0.57	1.14	1.72	1.14	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
seminal vesicle, adult	10201-103F3	15.34	2.65	1.06	5.29	1.59	0.00	0.00	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6.32	3.64	1.21	1.21	0.00	0.49	0.49	0.00	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	3.52	0.25	0.25	0.25	0.50	0.00	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	1.00	0.00	3.01	2.01	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	4.31	0.77	0.44	0.77	0.22	0.11	0.22	0.77	0.33	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	6.58	4.13	2.19	3.35	4.00	0.77	13.29	8.90	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	12.77	4.97	3.55	5.67	0.00	0.00	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	14.27	4.44	1.32	1.44	0.84	0.36	0.12	0.36	0.12	0.48
skeletal muscle, fetal, donor1	10066-101I3	10.05	7.04	10.05	9.05	1.01	0.00	0.00	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	6.79	0.00	6.79	0.00	0.00	13.57	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	15.78	4.42	10.73	4.42	0.63	0.63	1.26	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	13.67	3.34	2.67	1.67	0.67	0.67	0.00	0.00	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	36.88	12.61	21.12	16.71	0.32	3.47	0.32	0.32	1.89	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	12.14	1.16	0.96	1.73	0.00	0.19	0.00	0.00	1.35	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	65.63	11.26	14.32	10.62	0.16	2.41	0.00	0.16	2.09	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	65.81	31.60	15.69	11.99	1.96	1.74	1.31	0.65	3.70	2.83
small intestine, adult, pool1	10024-101D6	18.99	5.85	2.27	2.27	1.67	0.84	3.11	2.03	0.12	0.36
small intestine, fetal, donor1	10064-101I1	17.69	6.63	8.35	9.09	0.74	1.23	0.74	0.49	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.39	5.13	2.56	2.05	1.03	1.03	0.00	1.03	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	8.53	2.07	1.55	0.78	0.26	0.26	0.00	0.52	1.03	0.26
somatostatinoma cell line:QGP-1	10781-110G7	28.41	11.52	1.61	5.09	3.75	0.00	1.07	1.61	0.80	0.54
spinal cord - adult, donor10196	10181-103D1	9.41	2.75	9.64	5.28	0.46	1.84	0.23	0.00	0.92	0.23
spinal cord, adult, donor10252	10159-103A6	14.19	3.55	5.91	4.34	0.00	0.79	0.00	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	0.69	0.00	2.08	1.38	0.00	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	17.08	17.08	20.12	14.03	0.00	0.61	1.22	0.00	1.83	0.61
spinal cord, newborn, donor10223	10359-105E8	4.59	1.38	6.43	3.67	0.00	0.46	0.00	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.01	3.29	2.54	1.49	0.60	0.30	0.00	0.15	0.00	0.00
spleen, adult, pool1	10025-101D7	31.72	8.37	3.52	4.63	0.77	0.66	1.43	0.77	0.33	0.88
spleen, fetal, pool1	10044-101F8	55.06	20.98	1.83	4.13	1.35	1.19	1.11	1.27	0.32	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	12.53	4.37	3.99	3.42	4.37	0.19	3.04	1.52	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.28	5.59	10.83	13.28	2.10	2.45	2.45	2.80	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.14	4.84	4.50	4.16	1.35	0.34	0.90	1.46	0.23	1.69
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.42	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.00	4.23	1.69	2.12	0.00	0.00	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	20.29	8.54	1.07	5.34	6.41	2.14	7.48	5.34	0.00	1.07
submaxillary gland, adult	10202-103F4	9.68	5.13	3.42	2.85	2.28	0.00	0.00	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	597.02	325.64	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	8.31	3.32	3.12	2.49	0.42	0.21	0.42	0.00	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	3.62	0.52	4.66	0.52	0.00	0.00	0.00	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	5.65	1.41	9.89	3.53	1.41	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	9.40	0.92	1.15	1.60	0.00	0.00	0.00	0.23	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	29.67	8.56	2.29	3.39	0.34	1.27	0.51	0.08	2.71	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	98.29	31.34	69.09	42.02	0.00	0.71	0.00	0.00	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	83.51	24.61	16.70	22.86	0.44	0.88	0.44	0.88	3.08	1.32
tenocyte, donor1	11763-123H8	21.64	17.46	17.80	13.96	2.44	1.75	0.35	1.05	0.70	0.70
tenocyte, donor2	11765-123I1	18.69	14.12	9.92	5.34	1.53	1.91	1.14	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	16.31	17.79	17.79	7.78	2.22	0.74	2.22	1.48	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	15.13	4.76	8.33	4.42	0.17	0.34	0.00	0.00	1.36	1.87
teratocarcinoma cell line:NCR-G1	10798-110I6	2.93	0.62	1.08	0.00	0.00	0.46	0.00	0.31	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	1.39	0.15	0.93	0.15	0.00	0.00	0.00	0.15	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	8.12	5.84	1.78	1.14	0.76	0.76	0.13	0.13	0.25	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3.40	0.38	1.13	0.38	0.00	0.38	0.00	0.00	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.00	3.71	2.29	2.84	0.11	0.33	0.22	0.55	0.11	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.61	0.65	1.63	0.65	0.00	0.33	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	12.88	3.11	1.18	1.40	0.21	0.75	0.32	0.00	0.32	10.52
testis, adult, pool2	10096-102C6	6.32	1.35	3.61	4.51	0.45	0.45	0.45	0.00	0.00	12.63
thalamus - adult, donor10196	10168-103B6	8.83	1.10	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	9.69	2.97	3.28	1.41	0.00	0.31	0.00	0.00	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	0.00	4.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.43	0.99	3.62	1.98	0.00	0.16	0.00	0.00	0.16	0.49
thalamus, newborn, donor10223	10366-105F6	0.00	0.00	0.00	1.15	0.00	0.00	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	12.48	6.99	0.75	4.24	1.00	0.00	0.50	1.00	0.00	0.00
throat, fetal, donor1	10061-101H7	16.76	5.79	10.66	6.70	0.00	0.00	0.30	0.61	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	35.57	4.17	6.56	3.97	0.20	0.79	0.00	0.00	0.79	0.20
thymus, adult, pool1	10027-101D9	10.74	1.49	0.30	0.60	0.00	0.20	0.10	0.00	0.00	0.10
thymus, fetal, pool1	10043-101F7	22.13	4.16	1.25	1.87	0.31	0.31	0.00	0.10	0.21	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	0.53	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	0.42	0.28	0.00	0.00	0.14	0.00	0.00	0.14	0.00	0.00
thyroid, adult, pool1	10028-101E1	22.77	9.70	1.77	2.05	0.65	0.84	0.47	0.28	0.09	0.47
thyroid, fetal, donor1	10060-101H6	15.03	9.23	18.72	8.70	0.53	1.05	0.00	0.26	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	21.56	18.48	15.40	6.16	0.00	6.16	3.08	0.00	0.00
tongue, adult	10203-103F5	9.54	2.56	2.33	1.86	1.63	0.47	1.86	1.40	0.00	0.00
tongue, fetal, donor1	10059-101H5	12.61	7.49	7.88	7.49	0.00	2.76	0.00	0.79	0.00	0.39
tonsil, adult, pool1	10047-101G2	18.83	5.51	1.80	2.30	0.70	0.70	1.40	1.90	0.10	0.60
trachea, adult, pool1	10029-101E2	16.93	7.93	1.80	1.72	1.06	0.74	1.96	0.74	0.41	0.41
trachea, fetal, donor1	10058-101H4	15.39	7.31	4.62	3.85	1.15	0.38	0.38	0.77	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.98	6.38	7.09	5.67	1.77	0.35	0.35	0.00	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	5.27	0.71	0.20	0.10	0.20	0.10	0.51	0.71	0.30	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	28.54	7.61	1.90	9.51	3.81	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1.35	0.17	0.59	0.08	0.93	0.00	0.59	1.44	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	20.87	6.26	14.61	6.26	4.17	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	12.29	4.44	1.88	1.71	0.34	0.68	0.17	0.17	0.51	0.68
uterus, fetal, donor1	10055-101H1	16.38	4.61	7.17	2.56	0.00	0.51	0.00	0.00	0.00	0.00
vagina, adult	10204-103F6	20.03	4.52	0.65	0.00	0.00	0.65	0.65	0.00	1.29	0.65
vein, adult	10191-103E2	18.19	8.99	3.07	7.01	0.88	0.22	0.66	0.00	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00